logo
0001 IN UTERO STEM CELL TRANSPLANTATION IN NON-HUMAN PRIMATES: THE ROLE OF T-CELLS NUMBER
0002 CIPRACT (CERVICAL INCOMPETENCE PREVENTION RANDOMIZED CERCLAGE TRIAL): THERAPEUTIC CERCLAGE WITH BED REST VERSUS BED REST, FINAL RESULTS
0003 THE EFFECT OF ANTENATAL STEROIDS ON HEAD CIRCUMFERENCE AT BIRTH
0004 RANDOMIZED TRIAL OF INHALED BECLOMETHASONE VERSUS THEOPHYLLINE FOR ASTHMA DURING PREGNANCY
0005 EVIDENCE OF A GENE-ENVIRONMENT INTERACTION IN THE ETIOLOGY OF SPONTANEOUS PRETERM BIRTH
0006 REVISITING THE CLINICAL EFFICACY OF CERCLAGE IN THE TREATMENT OF SECOND-TRIMESTER SONOGRAPHICALLY DETECTED PREMATURE DILATION OF THE INTERNAL OS
0007 MECHANISMS OF VASORELAXATION BY CALCITONIN GENE RELATED PEPTIDE (CGRP) IN THE UTERINE VASCULAR BED OF PREGNANT RATS
0008 ELEVATED AMNIOTIC FLUID MATRIX METALLOPROTEINASE-8 AND THE SUBSEQUENT DEVELOPMENT OF CEREBRAL PALSY
0009 THE PRETERM PREDICTION STUDY: CERVICAL ALPHA-FETOPROTEIN LEVELS AND SPONTANEOUS PRETERM BIRTH IN ASYMPTOMATIC WOMEN
0010 MULTICENTER RANDOMIZED TRIAL OF SINGLE VERSUS WEEKLY COURSES OF ANTENATAL CORTICOSTEROIDS (ACS)
0011 THE RANDOMISED NITRIC OXIDE TOCOLYSIS TRIAL
0012 WEEKLY ANTENATAL STEROIDS IN WOMEN AT RISK FOR PRETERM BIRTH: A RANDOMIZED TRIAL
0013 PLASMA LEVELS OF THROMBIN-ANTITHROMBIN COMPLEXES PREDICT PRETERM PREMATURE RUPTURE OF THE FETAL MEMBRANES
0014 AN ELEVATED AMNIOTIC FLUID MATRIX METALLOPROTEINASE-8 AT THE TIME OF MIDTRIMESTER GENETIC AMNIOCENTESIS IDENTIFIES PATIENTS AT RISK FOR SPONTANEOUS PRETERM DELIVERY
0015 STEROIDS REDUCE FETAL GROWTH: ANALYSIS OF A PROSPECTIVE TRIAL
0016 NEUTROPHIL COLLAGENASE (MMP-8) IN AMNIOTIC FLUID IS A POWERFUL PREDICTOR OF IMPENDING PRETERM DELIVERY AND ADVERSE NEONATAL OUTCOME IN PRETERM LABOR WITH INTACT MEMBRANES
0017 EFFICACY OF WEEKLY COURSES OF ANTENATAL CORTICOSTEROIDS (ACS) IN PRETERM PREMATURE RUPTURE OF THE MEMBRANES
0018 ULTRASOUND MONITORING OF AMNIOTIC FLUID DEEPEST POOL IN PROLONGED PREGNANCY: AN ALTERNATIVE TO ROUTINE INDUCTION OF LABOR
0019 THIRD-TRIMESTER UNEXPLAINED INTRAUTERINE FETAL DEATH IS ASSOCIATED WITH INHERITED THROMBOPHILIA
0020 DOES PREGNANCY ALTER THE NORMAL DIASTOLIC PATTERNS DURING EXERCISE?
0021 BLOOD VOLUME STRATIFIED BY ANGIOTENSINOGEN GENOTYPES IN NORMAL AND HYPERTENSIVE PREGNANCY
0022 A POTENTIAL ROLE FOR HUMAN RECOMBINANT VASCULAR ENDOTHELIUM GROWTH FACTOR IN THE DEVELOPMENT OF VASCULAR DYSFUNCTION IN PREGNANCY
0023 MATERNAL SYSTEMIC INFLAMMATION: A MECHANISM OF DISEASE IN PREECLAMPSIA
0024 GRAVES’ DISEASE IN PREGNANCY—EVALUATION OF MANAGEMENT PROTOCOL WITH SELECTIVE USAGE OF UMBILICAL VEIN SAMPLING
0025 ELEVATED PLASMA HOMOCYSTEINE IN EARLY PREGNANCY: A RISK FACTOR FOR THE DEVELOPMENT OF SEVERE PREECLAMPSIA
0026 DIFFERENTIAL EXPRESSION OF THE CELL SURFACE RECEPTOR (CD95) FOR THE DEATH CELL FACTOR FAS-LIGAND IN PREECLAMPSIA AND MATERNAL INFECTION
0027 OXYTOCIN REGIMENS FOR THE PREVENTION OF UTERINE ATONY AT CESAREAN DELIVERY
0028 GRAM-NEGATIVE SEPSIS AMONG LOW-BIRTH-WEIGHT INFANTS: INFECTION RATES BEFORE AND AFTER INITIATION OF GROUP B STREPTOCOCCUS PROPHYLAXIS
0029 LEPTIN IN THE OVINE FETUS CORRELATES WITH FETAL AND PLACENTAL SIZE
0030 EFFECTIVENESS OF A RESCUE DOSE OF ANTENATAL BETAMETHASONE AFTER AN INITIAL SINGLE COURSE
0031 THERE IS NO ASSOCIATION BETWEEN MATERNAL THROMBOPHILIA AND RECURRENT FIRST-TRIMESTER LOSS
0032 CAN PRENATAL ULTRASOUND FINDINGS PREDICT AMBULATORY STATUS IN FETUSES WITH OPEN SPINA BIFIDA (OSB)?
0033 OPTIMAL PENICILLIN DOSING FOR GROUP B STREPTOCOCCUS PROPHYLAXIS
0034 IS NORMAL PREGNANCY CHARACTERIZED BY A STATE OF LEUKOCYTE ACTIVATION AKIN TO SEPSIS?
0035 OBESITY-ATTRIBUTABLE PERINATAL MORBIDITY: TEMPORAL TRENDS
0036 PROSTAGLANDIN E RECEPTOR mRNA EXPRESSION IN PREGNANT RAT MYOMETRIAL AND CERVICAL TISSUE
0037 SHARP VERSUS BLUNT EXPANSION OF THE UTERINE INCISION: INFLUENCE ON BLOOD LOSS
0038 UTERINE RUPTURE DURING A TRIAL OF LABOR AFTER A ONE- VERSUS TWO-LAYER CLOSURE OF A LOW TRANSVERSE CESAREAN
0039 SHOULD OBESE WOMEN ATTEMPT VAGINAL BIRTH AFTER CESAREAN?
0040 PATHWAYS INVOLVED IN UTERINE CONTRACTILITY: EFFECT OF GESTATION AGE AND LABOR
0041 INTRAPARTUM FETAL MONITORING: CARDIOTOCOGRAPHY VERSUS CARDIOTOCOGRAPHY PLUS FETAL ECG ST WAVEFORM ANALYSIS. A SWEDISH RANDOMIZED CONTROLLED TRIAL
0042 THE OCCURRENCE OF DYSTOCIA AMONG PATIENTS MONITORED IN LABOR WITH FETAL PULSE OXIMETRY
0043 A RANDOMIZED CONTROLLED TRIAL COMPARING PROPHYLACTIC ADMINISTRATION OF OXYTOCIN BEFORE AND AFTER PLACENTAL DELIVERY IN THE PREVENTION OF POSTPARTUM HEMORRHAGE
0044 INCREASED POLYMORPHONUCLEAR INFILTRATION AND AMNIOTIC BAND AFTER CLOSURE OF FETOSCOPIC ACCESS SITES WITH A BIO-ACTIVE MEMBRANE IN A RABBIT MODEL
0045 NEURONAL NITRIC OXIDE SYNTHASE (NNOS) REGULATES SPONTANEOUS AND ANGIOTENSIN II (ANG II)–STIMULATED FETAL SWALLOWING
0046 PERINATAL FACTORS PREDICTING SEVERE INTRACRANIAL HEMORRHAGE
0047 PREVENTION OF ALCOHOL-INDUCED PROINFLAMMATORY CYTOKINE RELEASE AND SPATIAL LEARNING DEFICITS WITH NOVEL PEPTIDES IN A MOUSE MODEL OF FETAL ALCOHOL SYNDROME
0048 THE MECHANISM OF OLIGOHYDRAMNIOS IN POSTDATES PREGNANCY: A PROSPECTIVE DOPPLER STUDY
0049 THE NEONATAL NUCLEATED RED BLOOD CELL INDEX: AN INDEPENDENT PROGNOSTIC INDICATOR FOR DEATH IN GROWTH-RESTRICTED NEONATES
0050 DOPPLER ULTRASONOGRAPHY FOR TIMING THE SECOND TRANSFUSION IN FETAL ANEMIA FROM RED CELL ALLOIMMUNIZATION
0051 RAPID TRANSITION OF FRESH HUMAN UMBILICAL CORD BLOOD MONONUCLEAR CELLS TO FETAL BLOOD FOLLOWING INJECTION INTO THE EXOCELOMIC CAVITY OF THE RABBIT
0052 DOPPLER VELOCIMETRY OF THE DISTAL RIGHT PULMONARY ARTERY AND THE DEVELOPMENT OF LUNG HYPOPLASIA
0053 REGRESSION ANALYSIS OF PERINATAL MORBIDITY FOR SECOND-TRIMESTER SONOGRAPHIC EVIDENCE OF INTERNAL OS DILATION AND SHORTENING OF THE DISTAL CERVIX
0054 ROLE OF ULTRASOUND FOR DOWN SYNDROME SCREENING OF THE ADVANCED MATERNAL AGE POPULATION
0055 THE COMPREHENSIVE MIDTRIMESTER TEST (CMT): HIGHLY SENSITIVE FOR DOWN SYNDROME DETECTION
0056 ACCURATE PREDICTION OF FETAL HEMOGLOBIN BY DOPPLER ULTRASONOGRAPHY: A PRELIMINARY STUDY.
0057 PRENATAL SCREENING STRATEGIES FOR DOWN SYNDROME T
0058 CERVICAL SONOGRAPHY IN PREDICTING SPONTANEOUS PRETERM BIRTH IN AT-RISK SINGLETON GESTATIONS
0059 PRENATAL UMBILICAL CORD VESSELS AREAS IN NORMAL AND GROWTH-RETARDED FETUSES
0060 MATERNAL THROMBOPHILIA IS ASSOCIATED WITH SECOND- AND THIRD-TRIMESTER FETAL DEATH
0061 ELEVATED AMNIOTIC FLUID C-REACTIVE PROTEIN AT THE TIME OF GENETIC AMNIOCENTESIS IS A MARKER FOR PRETERM DELIVERY
0062 ELECTRICAL INHIBITION OF UTERINE CONTRACTIONS: IN VITRO AND IN VIVO STUDIES
0063 DOES THE ANTENATAL USE OF CORTICOSTEROIDS AND ANTIBIOTICS INCREASE THE INCIDENCE OF LATE-ONSET NEONATAL SEPSIS IN VERY-LOW-BIRTH-WEIGHT INFANTS?
0064 THE HALIFAX COUNTY PRETERM BIRTH PREVENTION PROJECT
0065 ROLE OF AMNIOTIC FLUID MATRIX METALLOPROTEINASE-9 AND INTERLEUKIN-6 IN PREDICTION OF INTRA-AMNIOTIC INFECTION
0066 AMNIOTIC FLUID MATRIX METALLOPROTEINASE-8: AN INDEX OF FUNISITIS AND THE FETAL INFLAMMATORY RESPONSE SYNDROME
0067 PATIENTS WITH PRETERM LABOR AND A SHORT CERVIX ARE AT INCREASED RISK FOR INTRAUTERINE INFLAMMATION AND PRETERM DELIVERY
0068 THE DIAGNOSTIC AND PROGNOSTIC VALUE OF MMP-8 IN THE EVALUATION OF PRETERM LABOR
0069 BETAMETHASONE SUPPRESSION OF SALIVARY ESTRIOL
0070 THE PRETERM PREDICTION STUDY: CERVICAL HUMAN CHORIONIC GONADOTROPIN LEVELS AND SPONTANEOUS PRETERM BIRTH IN ASYMPTOMATIC WOMEN
0071 SEROLOGIC MARKERS AT 22 TO 24 WEEKS’ GESTATION IMPROVE THE PREDICTION OF SUBSEQUENT SPONTANEOUS PRETERM BIRTH
0072 IMPROVED OUTCOME WITH EARLY-ONSET PREMATURE RUPTURE
0073 INCREASED CYTOKINE PRODUCTION AFTER LPS STIMULATION OF WHOLE BLOOD MAY BE A RISK FACTOR FOR PRETERM BIRTH
0074 TOCOLYTIC AGENTS ARE INEFFECTIVE AFTER PRETERM RUPTURE OF THE MEMBRANES
0075 IN VITRO SEALING OF FETAL MEMBRANES
0076 DOES CERVICAL DILATATION AT PRESENTATION INFLUENCE THE INTERVAL TO SUBSEQUENT PRETERM BIRTH?
0077 SINGLE VERSUS MULTICOURSE STEROIDS FOR FETAL MATURATION IN WOMEN WITH PRETERM PREMATURE RUPTURE OF MEMBRANES (PPROM)
0078 REPEATED COURSES OF ANTENATAL CORTICOSTEROIDS: A SYSTEMATIC REVIEW AND META-ANALYSIS
0079 DOES THE ADDITION OF BIOCHEMICAL MARKERS IMPROVE THE PREDICTION OF PRETERM DELIVERY BY TRANSVAGINAL ULTRASOUND OF THE CERVIX?
0080 FETAL CARRIAGE OF IL-1β*2 IS NOT ASSOCIATED WITH PREMATURE MEMBRANE RUPTURE AND PRETERM DELIVERY
0081 FETAL FIBRONECTIN AS A PREDICTOR OF PRETERM DELIVERY IN SYMPTOMATIC PATIENTS
0082 DELIVERY AT 34 WEEKS IS MORE COSTLY THAN AT 35 WEEKS IN THE SETTING OF PPROM
0083 PERIODONTAL DISEASE AND PRETERM BIRTH
0084 THE ENDOTHELIN-1 PATHWAY IN A PRETERM LABOR ANIMAL MODEL
0085 EFFECTS OF ANTENATAL BETAMETHASONE AFTER PRETERM PREMATURE RUPTURE OF MEMBRANES (PPROM) BETWEEN 24 AND 32 WEEKS OF GESTATION
0086 HIGH PREVALENCE OF THROMBOPHILIA IN WOMEN WITH PRETERM DELIVERY OR LATE SECOND-TRIMESTER ABORTION
0087 THE SIGNIFICANCE OF AN INCREASED AMNIOTIC FLUID C-REACTIVE PROTEIN CONCENTRATION IN PATIENTS WITH PRETERM LABOR BEFORE 34 WEEKS OF GESTATION
0088 THE POTENTIAL ROLE OF THROMBIN IN PRETERM PARTURITION
0089 THE CORRELATION BETWEEN PLACENTAL HISTOPATHOLOGY AND PERINATAL OUTCOME IN PRETERM INFANTS
0090 EFFECTIVENESS OF ANTENATAL STEROIDS: IS MORE BAD?
0091 PRETERM PREMATURE RUPTURE OF MEMBRANES: REEVALUATION OF RECURRENCE RATES AND ITS IMPLICATIONS ON PRETERM DELIVERY IN THE NEXT PREGNANCY
0092 IMPACT OF MATERNAL AGE ON PREGNANCY OUTCOME IN SINGLETON PREGNANCIES WITH A HISTORY OF PREVIOUS PRETERM DELIVERY
0093 PREGNANT WOMEN WITH UTERINE CONTRACTIONS HAVE LOWER END-TIDAL CARBON MONOXIDE LEVELS
0094 GROWTH DEFICIENCY IN FETUSES DESTINED TO DELIVER PRETERM
0095 RECURRENCE RATE OF PRETERM PREMATURE RUPTURE OF MEMBRANES
0096 GROWTH AND FERTILITY OF RATS EXPOSED IN UTERO TO PREGNANCY-PROLONGING TREATMENT WITH A CYCLOOXYGENASE II INHIBITOR
0097 SONOGRAPHIC DESCRIPTION OF THE CERVIX AT RISK FOR PRETERM BIRTH
0098 OBSTETRIC AND EARLY NEONATAL PARAMETERS ARE NOT PREDICTIVE FOR DEVELOPING BRONCHOPULMONARY DYSPLASIA (BPD) IN VERY-LOW-BIRTH-WEIGHT (VLBW) NEONATES
0099 PERINATAL PROTECTING FACTORS AGAINST DEVELOPMENT OF INTRAVENTRICULAR HEMORRHAGE (IVH) IN VERY-LOW-BIRTH-WEIGHT (VLBW) NEONATES
0100 STEROID TREATMENT DOES NOT ALTER NEONATAL MORBIDITY IN VERY-LOW-BIRTH-WEIGHT (VLBW) INFANTS
0101 ENDOGENOUS DEGRANULATION OF UTERINE MAST CELLS STIMULATES UTERINE CONTRACTILITY IN PREGNANT HUMANS
0102 EVALUATION OF PARTICIPATION IN A PRETERM BIRTH PREVENTION PROJECT
0103 GESTATIONAL GAIN FOLLOWING DIAGNOSIS OF PRETERM LABOR WITH ADVANCED CERVICAL DILATATION
0104 INDEPENDENT RISK FACTORS FOR REHOSPITALIZATION AFTER TERM VAGINAL DELIVERY
0105 RISK FACTORS FOR RECURRENT SPONTANEOUS PRETERM DELIVERY
0106 MATERNAL HYPERTENSIVE DISORDERS ARE AN INDEPENDENT RISK FACTOR FOR THE DEVELOPMENT OF NECROTIZING ENTEROCOLITIS IN PRETERM NEONATES
0107 PRETERM PREMATURE RUPTURE OF MEMBRANES IN VERY-LOW-BIRTH-WEIGHT NEONATES IS NOT ASSOCIATED WITH INCREASED RATES OF NEONATAL MORBIDITY
0108 DOES THE ADMISSION-TO-DELIVERY INTERVAL INFLUENCE THE OUTCOME OF PRETERM DELIVERY REGARDING THE PRESENCE OR ABSENCE OF PPROM?
0109 AN IMPACT OF ANTENATAL GLUCOCORTICOID TREATMENT ON PERIVENTRICULAR LEUKOMALACIA IN VERY-LOW-BIRTH-WEIGHT NEONATES
0110 CLINICAL SIGNIFICANCE OF PRETERM PREMATURE RUPTURE OF MEMBRANES IN PRETERM LABOR: A PROSPECTIVE STUDY
0111 UTERINE CONTRACTION FREQUENCY DOES NOT PREDICT PRETERM BIRTH IN TWINS
0112 IS A POSITIVE CERVICAL FIBRONECTIN A MARKER OF AN UPPER GENITAL TRACT INFECTION?
0113 TNF-αAND IL-6 EXPRESSION IS PROMOTED IN PRETERM HUMAN PLACENTAE
0114 AMNIOTIC FLUID MAGNESIUM ACCUMULATION WITH STABLE MATERNAL SERUM CONCENTRATIONS
0115 THE ASSOCIATION OF RATE OF RISE IN SALIVARY ESTRIOL WITH PRETERM DELIVERY
0116 ACUTE INFLAMMATORY PLACENTAL LESIONS IN PATIENTS WITH A SHORT CERVIX AND EARLY PRETERM DELIVERY
0117 EVIDENCE FOR A SYSTEMIC MATERNAL INFLAMMATORY RESPONSE IN PRETERM PARTURITION
0118 EVIDENCE OF SUBCLINICAL SYSTEMIC MATERNAL INFLAMMATION IN PRETERM PREMATURE RUPTURE OF MEMBRANES
0119 MATERNAL INFLAMMATION ALTERS FETAL REDOX STATUS AND SURVIVAL IN A MODEL OF PREMATURITY
0120 ANTENATAL CORTICOSTEROIDS COMPROMISE NEONATAL HEIGHT AT TERM
0121 SINGLE-VERSUS MULTIPLE-DOSE ANTENATAL STEROIDS AND THE EFFECT ON BLOOD PRESSURE IN LOW-BIRTH-WEIGHT NEONATES
0122 ELEVATED LEVELS OF AMNIOTIC FLUID GLUTAMATE AND TAURINE ARE INDICATIVE OF PRETERM INTRAVENTRICULAR HEMORRHAGE (IVH) AND PERIVENTRICULAR LEUKOMALACIA (PVL)
0123 MONOCLONAL ANTIBODIES TO OXYTOCIN AS POSSIBLE INHIBITORS OF OXYTOCIN BINDING TO ITS RECEPTOR
0124 EXPECTANT MANAGEMENT OF PRETERM PREMATURE RUPTURE OF MEMBRANES AT 24 TO 28 WEEKS: DOES PROLONGING LATENCY IMPROVE NEONATAL OUTCOME?
0125 SUBCLINICAL INTRA-AMNIOTIC INFECTION INCREASES NEONATAL MORBIDITY IN PATIENTS WITH PRETERM PREMATURE RUPTURE OF MEMBRANES
0126 FETAL FIBRONECTIN IS A VALID PREDICTOR OF PRETERM DELIVERY IN PATIENTS FOLLOWING MULTIFETAL PREGNANCY REDUCTION
0127 SPONTANEOUS VERSUS CORTICOSTEROID-INDUCED LUNG MATURITY: IS THERE A DIFFERENCE IN NEONATAL OUTCOME?
0128 PRETERM PROM AND PLACENTAL ABRUPTIO
0129 HISTOLOGIC PLACENTAL LESIONS IN WOMEN WITH RECURRENT PRETERM DELIVERY
0130 SEXUAL ORIGIN OF PLACENTAL DYSFUNCTION IN SEVERE PREMATURITY
0131 RISK FOR RECURRENT PRETERM DELIVERY AMONG WOMEN WHO HAVE HAD THREE BIRTHS
0132 EXAMINATION OF RISK FACTORS FOR NEONATAL MORTALITY AMONG EXTREMELY LOW-BIRTH-WEIGHT INFANTS IN MISSOURI 1989-1997
0133 TRANSVAGINAL ULTRASOUND OF THE CERVIX IDENTIFIES IMPENDING DELIVERY IN PATIENTS WITH PRETERM PREMATURE RUPTURE OF MEMBRANES
0134 PERSISTENCE OF ELEVATED SERUM MAGNESIUM LEVELS IN THE NEONATE
0135 ANTENATAL/POSTNATAL STEROIDS AND DEVELOPMENTAL OUTCOME AT AGE 2 YEARS
0136 THE EFFECT OF ANTENATAL AND POSTNATAL STEROID ON WEIGHT GAIN IN THE NURSERY
0137 EFFECT OF ANTENATAL AND POSTNATAL STEROID ON HEAD CIRCUMFERENCE GROWTH IN THE NURSERY
0138 DOES EARLY DISCHARGE AFFECT ADEQUACY OF NEWBORN METABOLIC SCREENING?
0139 DELIVERY AT 34 TO 37 WEEKS: IS THE DANGER OVER?
0140 NEONATAL OUTCOMES FOLLOWING ELECTIVE INDUCTION OF LABOR
0141 PERINATAL OUTCOME OF INFANTS BORN AT 23 WEEKS’ GESTATION
0142 THE EFFECT OF IN UTERO EXPOSURE TO GENTAMICIN ON NEWBORN OTOACOUSTIC EMISSIONS
0143 INTRACRANIAL INJURY IS NOT RELATED TO MODE OF DELIVERY IN INFANTS WITH A BIRTH WEIGHT >2500 g
0144 NEONATAL CEREBRAL INFARCTION: CLINICAL ASSOCIATIONS
0145 PERINATAL ASPHYXIA: ANALYSIS OF A DATABASE FROM A NEONATAL REFERRAL CENTER
0146 TOXIC EXPOSURE DURING PREGNANCY. REPORT FROM A NATIONAL DATABASE—1999
0147 MANAGED CARE PENETRATION IS NOT ASSOCIATED WITH PERINATAL DEREGIONALIZATION IN WASHINGTON STATE
0148 MATERNAL QUALITY OF LIFE IN THE YEAR FOLLOWING DELIVERY: DEVELOPMENT AND VALIDATION OF A NEW ASSESSMENT TOOL
0149 THE GEOGRAPHIC DISTRIBUTION OF ADVANCED MATERNAL AGE IN THE UNITED STATES FROM 1989 TO 1997
0150 DOES THE KESSNER INDEX REFLECT TRENDS IN THE NUMBER OF DOWN SYNDROME LIVE BIRTHS IN THE UNITED STATES?
0151 TRENDS IN DOWN SYNDROME BIRTHS IN THE U. S. FROM 1989 TO 1998: AN ANALYSIS BY MATERNAL AGE.
0152 THE EFFECT OF COMBINED USE OF VACUUM AND FORCEPS FOR ASSISTED VAGINAL DELIVERY ON NEONATAL AND MATERNAL OUTCOMES
0153 DOES PRENATAL CARE IN THE UNITED STATES PREVENT FETAL DEATH?
0154 DOES PRENATAL CARE IN THE UNITED STATES HAVE AN IMPACT ON NEONATAL DEATH?
0155 GRIP—GETTING RESEARCH INTO PRACTICE: HAVE RANDOMIZED CONTROLLED TRIALS IMPROVED OUTCOMES IN POSTTERM PREGNANCIES?
0156 DO PRIMARY CESAREAN DELIVERY RATES CORRELATE WITH RATES OF POOR NEONATAL OUTCOMES?
0157 RISK FOR INFANT DEATH BY GESTATIONAL AGE AT DELIVERY IN PREGNANCIES COMPLICATED BY PREECLAMPSIA/ECLAMPSIA: A POPULATION-BASED STUDY
0158 TERM INTRAPARTUM FEVER, INTERLEUKIN 6, HISTOLOGIC INFLAMMATION, AND NEONATAL SEPSIS STATUS
0159 OUTCOME OF PREGNANCIES WITH A TRUE KNOT IN THE UMBILICAL CORD
0160 ROUTINE ULTRASOUND SCREENING IN A SINGLE TERTIARY CARE CENTER—A COST-BENEFIT ANALYSIS
0161 BIRTH WEIGHT FOR GESTATIONAL AGE PERCENTILES IN THE PREDICTION OF PERINATAL OUTCOME AT TERM
0162 DO MACROSOMIC BABIES EXPOSED TO LABOR HAVE AN ALTERED INFANT MORTALITY RATE?
0163 OBESITY AND ALCOHOL CONSUMPTION AS ETIOLOGIC RISK FACTORS FOR CONGENITAL DIAPHRAGMATIC HERNIA
0164 PERINATAL MORTALITY AMONG BIRTH WEIGHT–DISCORDANT TWINS IN MISSOURI
0165 RISK DRINKING IN A PREGNANT INNER-CITY POPULATION DETERMINED BY COMPUTER-ASSISTED INTERVIEWING
0166 DOES RISK-FREE PREGNANCY IMPLY RISK-FREE DELIVERY?
0167 PERINATAL OUTCOME OF BREECH DELIVERY AT TERM: AN EPIDEMIOLOGIC STUDY
0168 DOES THE LACK OF PRENATAL CARE DIFFERENTIALLY AFFECT WOMEN IN THE VARIOUS GEOGRAPHIC AREAS OF THE UNITED STATES?
0169 RE-ESTIMATION OF THRESHOLD FOR FETAL ALCOHOL SYNDROME (FAS) USING NONLINEAR REGRESSION
0170 POPULATION-BASED DEFINITION OF DISCORDANT GROWTH PREDICTS COMPLICATIONS OF TWIN PREGNANCY
0171 PRENATAL SUBSTANCE USE AND PRETERM DELIVERY RISK FOR OLDER AND YOUNGER WOMEN
0172 AN ECONOMIC EVALUATION OF THE TECHNOLOGIES FOR PRENATAL SCREENING FOR DOWN SYNDROME
0173 IS AN ELEVATED MATERNAL SERUM HUMAN CHORIONIC GONADOTROPIN LEVEL ASSOCIATED WITH ADVERSE PERINATAL OUTCOMES?
0174 NEURAL TUBE DEFECTS: IS A CHANGING PREVALENCE ASSOCIATED WITH A CHANGE IN SEVERITY?
0175 RISKS OF FETAL GROWTH RESTRICTION AND PRETERM DELIVERY IN RELATION TO PLACENTA PREVIA: A POPULATION-BASED STUDY
0176 OBTAINING BIRTH CERTIFICATE DATA: IS IT ACCURATE?
0177 THE UNIQUE CONTRIBUTIONS OF ALCOHOL USE AND DRUG USE TO REDUCTIONS IN BIRTH WEIGHT IN POLYSUBSTANCE-EXPOSED INFANTS
0178 COMMUNITY-BASED EDUCATION INCREASES CORTICOSTEROID USE BEFORE PRETERM BIRTH
0179 EVIDENCE FOR A MARKED DECREASE IN THE INCIDENCE OF INTRAHEPATIC CHOLESTASIS OF PREGNANCY OVER THE LAST DECADE
0180 ANTENATAL DIAGNOSIS OF FETAL CARDIAC ANOMALIES IN WOMEN WITH DIABETES MELLITUS
0181 DEVELOPMENT OF A COST-EFFECTIVE SCREEN FOR GESTATIONAL DIABETES
0182 THE RELATIONSHIP BETWEEN BODY MASS INDEX AND GLUCOSE TOLERANCE TESTING IN MULTIFETAL GESTATIONS
0183 PREGNANT WOMEN LACKING CIRCULATING RELAXIN HAVE DECREASED INSULIN SENSITIVITY
0184 THE FASTING PLASMA GLUCOSE IN EARLY PREGNANCY: A SCREENING TEST FOR GESTATIONAL DIABETES
0185 PATIENTS WITH A FALSE POSITIVE 1-HOUR GLUCOSE CHALLENGE TEST (GCT) ARE AT INCREASED RISK FOR PERINATAL COMPLICATIONS
0186 FETAL FAT TISSUE GROWTH IN PREGNANCIES COMPLICATED BY GESTATIONAL DIABETES
0187 NO ASSOCIATION BETWEEN FETAL MACROSOMIA AND MATERNAL GLYCEMIC VALUES IN PREGNANCIES WITH GESTATIONAL DIABETES
0188 PERINATAL OUTCOMES IN GESTATIONAL DIABETES: A COMPARISON OF CRITERIA FOR DIAGNOSIS
0189 SPONTANEOUS PRETERM BIRTH IN TYPE I DIABETIC PREGNANCY: THE ROLE OF GLYCEMIC CONTROL
0190 ONE- VERSUS TWO-HOUR POSTPRANDIAL GLUCOSE MEASUREMENT IN GESTATIONAL DIABETES—A PROSPECTIVE STUDY
0191 CORRECTION FOR INSULIN DEPENDENT DIABETES IN ALPHAFETOPROTEIN TESTING HAS OUTLIVED ITS USEFULNESS
0192 FASTING INSULIN AND GLUCOSE-TO-INSULIN RATIO IN THE DIAGNOSIS OF GESTATIONAL DIABETES MELLITUS
0193 PRECONCEPTION VS EARLY PREGNANCY CARE AND ADVERSE PREGNANCY OUTCOME IN TYPE I DIABETES
0194 PERINATAL OUTCOME IN WOMEN WITH RECURRENT PREECLAMPSIA COMPARED TO THOSE WHO DEVELOP PREECLAMPSIA AS NULLIPARA
0195 RESPIRATORY DISTRESS SYNDROME (RDS) IN PRETERM INFANTS OF DIABETIC AND NONDIABETIC MOTHERS
0196 CHANGE OF MACROSOMIA RATE IN PREGNANCIES WITH DIABETES WHEN INCLUDING NEONATAL AND MATERNAL ANTHROPOMETRY
0197 THE RATE OF PREECLAMPSIA IN WOMEN WITH GESTATIONAL DIABETES IS COMPARABLE TO THE GENERAL POPULATION
0198 FETAL MACROSOMIA: IS IT LIPID PROFILE OR LEVEL OF GLYCEMIA?
0199 DIABETES IN PREGNANCY: DOES GOOD GLYCEMIC CONTROL AND NORMAL NEONATAL SIZE PROTECT THE FETUS FROM HIGHER RATES OF SHOULDER DYSTOCIA?
0200 DOES LISPRO INSULIN CROSS THE HUMAN PLACENTA?
0201 COMPLICATIONS IN GESTATIONAL AND PRE-GESTATIONAL DIABETIC WOMEN
0202 DIFFERENCES IN NEONATAL OUTCOMES IN CLASS C/D AND CLASS R/F DIABETES
0203 END TIDAL CARBON MONOXIDE LEVELS ARE LOWER IN WOMEN WITH GESTATIONAL HYPERTENSION AND PREECLAMPSIA
0204 SIDE-TO-SIDE DIFFERENCES IN TRANSCRANIAL DOPPLER PARAMETERS IN NORMOTENSIVE AND PREECLAMPTIC PREGNANT WOMEN
0205 TRANSCRANIAL DOPPLER MEASUREMENT OF CEREBRAL VELOCITY INDICES AS A PREDICTOR OF PREECLAMPSIA?
0206 MATERNAL SERUM PLACENTA GROWTH FACTOR AND VASCULAR ENDOTHELIAL GROWTH FACTOR IN PREGNANCIES COMPLICATED BY PREECLAMPSIA
0207 ELEVATED CELLULAR ADHESION MOLECULE CONCENTRATIONS IN MID-PREGNANCY MAY PREDICT RECURRENT PREECLAMPSIA
0208 RELATIONSHIP OF TWIN ZYGOSITY AND PREECLAMPSIA
0209 CORRELATION OF QUANTITATIVE PROTEIN MEASUREMENTS IN 8-, 12- AND 24-HOUR URINE SAMPLES FOR THE DIAGNOSIS OF PREECLAMPSIA
0210 THE ANGIOTENSIN II RECEPTOR I 1166A TO C ALLELIC VARIANT IS NOT ASSOCIATED WITH PREECLAMPSIA
0211 GENETIC SUSCEPTIBILITY TO PREECLAMPSIA: ROLES OF Asp9Asn MUTATION, –93G PROMOTER MUTATION, Asn291Ser MUTATION IN THE LIPOPROTEIN LIPASE GENE
0212 GENETIC POLYMORPHISMS WITHIN THE INTERLEUKIN-1ß PATHWAY AND PREECLAMPSIA
0213 PREECLAMPSIA: WILL IT HAPPEN AGAIN?
0214 HEAT SHOCK PROTEIN 70 CONCENTRATIONS ARE NOT INCREASED IN SEVERE PREECLAMPSIA
0215 PLACENTAL GROWTH FACTOR IS NOT AN EARLY MARKER FOR THE DEVELOPMENT OF SEVERE PREECLAMPSIA
0216 LONG-CHAIN 3 HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY IS UNCOMMON IN PREGNANCIES COMPLICATED BY FULL/PARTIAL HELLP SYNDROME OR ACUTE FATTY LIVER OF PREGNANCY
0217 OBSTETRICAL INTERVENTION, MATERNAL AND NEONATAL OUTCOMES OF WOMEN WITH GESTATIONAL HYPERTENSION
0218 THE INFLUENCE OF GESTATIONAL AGE ON THE EFFECTIVENESS OF LOW-DOSE ASPIRIN FOR THE PREVENTION OF HYPERTENSIVE DISEASE AND GROWTH RESTRICTION IN PREGNANCY
0219 IN PREECLAMPSIA, MACROPHAGES MAY INDUCE TROPHOBLAST APOPTOSIS IN THE PLACENTAL BED BY DECREASING TRYPTOPHAN CONCENTRATION
0220 INCREASED ERYTHROCYTE ADHESIVENESS/AGGREGATION IN THE PERIPHERAL VENOUS BLOOD OF WOMEN WITH PREGNANCY INDUCED HYPERTENSION
0221 ANGIOTENSINOGEN T235 EXPRESSION IS ELEVATED IN FETAL LIVER
0222 UTILITY OF A RANDOM PROTEIN TO CREATININE RATIO AS A PREDICTOR OF SIGNIFICANT PROTEINURIA
0223 UNBOUND ACTIVIN A, INHIBIN A, AND FOLLISTATIN IN SERUM AND URINE OF WOMEN WITH PREECLAMPSIA
0224 VEGF GENE EXPRESSION IS INCREASED IN THE DECIDUA OF PRETERM PREECLAMPTIC PATIENTS
0225 LIPIDE PEROXIDATION AND TOTAL PEROXYL RADICAL-TRAPPING ABILITY OF UMBILICAL VENOUS BLOOD PLASMA IN NORMAL PREGNANCY AND PREECLAMPSIA
0226 NITRIC OXIDE OF THE UTERINE, UMBILICAL, AND ANTECUBITAL VENOUS BLOOD IN WOMEN WITH PREECLAMPSIA
0227 T-CELL ZETA CHAIN EXPRESSION IN WOMEN WITH PREECLAMPSIA COMPARED TO NORMOTENSIVE PREGNANT CONTROLS
0228 ROLES OF NITRIC OXIDE AND POTASSIUM CHANNELS IN THE VASCULAR EFFECT OF VASOPRESSIN IN PREGNANCY
0229 REPEAT POSTPARTUM MAGNESIUM SULFATE ADMINISTRATION FOR SEIZURE PROPHYLAXIS: IS THERE A PATIENT PROFILE PREDICTIVE OF NEED FOR ADDITIONAL THERAPY?
0230 FIRST TRIMESTER MATERNAL SERUM URIC ACID, LIPIDS, LIPOPROTEINS AND OBESITY IN RELATION TO THE RISK OF PREECLAMPSIA.
0231 ELEVATED FIRST TRIMESTER SERUM C-REACTIVE PROTEIN AND SUBSEQUENT RISK OF PREECLAMPSIA
0232 A PROSPECTIVE STUDY OF MATERNAL DIETARY AND PLASMA FOLATE, VITAMIN B12 AND HOMOCYSTINE STATUS IN RELATION TO PREECLAMPSIA RISK
0233 NICOTINE INHIBITS INTERCELLULAR ADHESION MOLECULE EXPRESSION ON ENDOTHELIAL CELLS IN VITRO
0234 MATERNAL FIRST-TRIMESTER PLASMA ASCORBIC ACID (VITAMIN C) CONCENTRATIONS IN RELATION TO RISK OF PREECLAMPSIA
0235 VASCULAR REACTIVITY DURING PREGNANCY IN TRANSGENIC MICE LACKING ENDOTHELIAL NITRIC OXIDE SYNTHASE
0236 VASCULAR EFFECT OF MAGNESIUM SULPHATE IN TRASGENIC MICE LACKING ENDOTHELIAL NITRIC OXIDE SYNTHASE
0237 UTERINE CONTRACTILITY IN PREGNANT MICE LACKING AN INDUCIBLE NITRIC OXIDE SYNTHASE
0238 THE SEVERITY OF PREECLAMPSIA AND THE TIMING OF DELIVERY INFLUENCES THE SEVERITY AND RECURRENCY RATE OF PREECLAMPSIA AMONG PRIMIPAROUS WOMEN WITH PREECLAMPSIA
0239 MATERNAL ECHOCARDIOGRAPHIC ALTERATIONS IN ASYMPTOMATIC 24 WEEKS UTERINE ARTERY BILATERAL NOTCHES
0240 MILD GESTATIONAL HYPERTENSION: RACIAL DIFFERENCES ARE ASSOCIATED WITH ALTERED OUTCOMES IN WOMEN UNDERGOING OUTPATIENT MANAGEMENT
0241 SUBSEQUENT PREGNANCY OUTCOMES IN WOMEN WITH A HISTORY OF HELLP SYNDROME ≤ 30 WEEKS
0242 SERUM LEVELS OF ESTROGENS IN WOMEN WITH PREECLAMPSIA
0243 17β ESTRADIOL IMPROVES FLOW-MEDIATED DILATATION IN MYOMETRIAL RESISTANCE ARTERIES FROM WOMEN WITH PREECLAMPSIA
0244 INDUCTION OF LABOR VS PLANNED CESAREAN DELIVERY < 34 WEEKS’ GESTATION WITH SEVERE GESTATIONAL HYPERTENSION
0245 MATERNAL HEMOLYSIS, ELEVATED LIVER ENZYMES AND LOW PLATELETS (HELLP) SYNDROME: PERINATAL AND NEONATAL OUTCOMES
0246 ANGIOTENSINOGEN IS EXPRESSED AND T235 EXPRESSION IS PREFERENTIALLY EXPRESSED DURING HUMAN RENAL DEVELOPMENT
0247 IS A POLICY OF PROPHYLACTIC MAGNESIUM SULFATE FOR ALL PREECLAMPTIC PATIENTS IN LABOR WORTHWHILE?
0248 RELATIONSHIP OF VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) AND PLACENTAL GROWTH FACTOR (PLGF) IS ALTERED IN PREECLAMPSIA
0249 DO WOMEN AT HIGH RISK DEVELOP PREECLAMPSIA EARLIER IN GESTATION THAN THOSE AT LOW RISK?
0250 A COMPARISON OF INDUCTION TO DELIVERY INTERVALS IN PATIENTS WITH PREECLAMPSIA VS NORMOTENSIVE CONTROLS
0251 DIURNAL VARIATION IN BLOOD PRESSURE AND SUBSEQUENT RELATION TO OUTCOMES IN WOMEN WITH GESTATIONAL HYPERTENSION
0252 PRETERM PREECLAMPSIA WITH FETAL GROWTH RESTRICTION IS A MORE SEVERE PLACENTAL DISEASE THAN PRETERM PREECLAMPSIA ALONE
0253 IMPACT OF DIFFERENT PREVENTION STRATEGIES ON NEONATAL GROUP B STREPTOCOCCAL DISEASE: AN ITALIAN EXPERIENCE
0254 VASCULAR CELL ADHESION MOLECULE AND LOW-DENSITY LIPOPROTEIN OXIDATION IN PREECLAMPSIA
0255 FREQUENCY OF NUCLEOSIDE A IN AFRICAN AMERICAN WOMEN WITH PREGNANCY-INDUCED HYPERTENSION.
0256 THE EFFECT OF BACTERIAL VAGINOSIS TREATMENT ON THE ACQUISITION OF OTHER SYMPTOMATIC SEXUALLY TRANSMITTED DISEASES DURING PREGNANCY
0257 ENDOMETRIAL MICROBIAL COLONIZATION IS INCREASED IN WOMEN WITH ASYMPTOMATIC BACTERIAL VAGINOSIS
0258 ANTIMICROBIAL SUSCEPTIBILITY OF GRAM-NEGATIVE UROPATHOGENS ISOLATED FROM OBSTETRIC PATIENTS
0259 A COMPARISON OF AMNIOTIC FLUID IL-12, IL-6, MMP-9, AND GLUCOSE FOR DIAGNOSING SUBCLINICAL CHORIOAMNIONITIS
0260 LOW VIRULENCE GROUP B STREPTOCOCCUS SEROTYPES: A POSSIBLE EXPLANATION FOR THE LOW INCIDENCE OF EARLY-ONSET NEONATAL DISEASE IN SOUTHERN ISRAEL
0261 SIGNIFICANT DECREASE IN EARLY-ONSET NEONATAL SEPSIS CAUSED BY GROUP B STREPTOCOCCUS AND OTHER PENICILLIN-SUSCEPTIBLE ORGANISMS IN AN ERA OF GROUP B STREPTOCOCCUS INTRAPARTUM ANTIBIOTIC PROPHYLAXIS
0262 HIV INFECTION IS A RISK FACTOR FOR ADVERSE PERINATAL OUTCOME
0263 MATRIX METALLOPROTEINASE-9 AND APOPTOSIS (FAS/FAS LIGAND SYSTEM) IN INTRA-AMNIOTIC INFECTION
0264 THE ROLE OF CYTOKINES AND FAS/FAS LIGAND SYSTEM IN INTRA-AMNIOTIC INFECTION
0265 PREMATURE RUPTURE OF MEMBRANES AFTER 35 WEEKS: A RANDOMIZED CLINICAL TRIAL OF INDUCTION OF LABOR WITH ORAL VERSUS VAGINAL ADMINISTRATION OF MISOPROSTOL
0266 MULTIANTIVIRAL THERAPY FOR HIV IN PREGNANCY IS NOT ASSOCIATED WITH INCREASED ADVERSE PERINATAL OUTCOME
0267 STATE-MANDATED PRENATAL SCREENING FOR HUMAN IMMUNODEFICIENCY VIRUS AT A LARGE COMMUNITY HOSPITAL
0268 THE CLINICAL SIGNIFICANCE OF INTRA-AMNIOTIC INFLAMMATION IN PATIENTS WITH PRETERM LABOR AND INTACT MEMBRANES
0269 MECONIUM PASSAGE AND RISK OF INFECTION AT TERM
0270 ASSESSING THE TERATOGENIC POTENTIAL OF ANTIRETROVIRAL DRUGS: DATA FROM THE ANTIRETROVIRAL PREGNANCY REGISTRY
0271 VERTICAL TRANSMISSION OF HIV WITH HAART: REDUCTION IN TRANSMISSION MAY BE INDEPENDENT OF VIRAL LOAD
0272 MULTIPLE DRUG ANTIVIRAL THERAPY FOR HIV IN PREGNANCY IS NOT ASSOCIATED WITH INCREASED ADVERSE PERINATAL OUTCOME
0273 SUDDEN α1-ANTITRYPSIN (α1-AT) SERUM ELEVATION AS A MARKER OF CHORIOAMNIONITIS
0274 NERVE GROWTH FACTOR AND BRAIN-DERIVED NEUROTROPHIC FACTOR CONCENTRATION IN MATERNAL SERUM AND AMNIOTIC FLUID
0275 DETERMINANTS OF NUCLEATED RED BLOOD CELL COUNTS IN TERM NEONATES?
0276 COMPARISON OF ADRENOMEDULLIN AND ADRENOMEDULLIN RECEPTOR mRNA EXPRESSION IN PLACENTAS FROM NORMAL AND COMPLICATED PREGNANCIES
0277 DOCUMENTATION OF AMNIOTIC FLUID EMBOLUS VIA LUNG HISTOPATHOLOGY: FACT OR FICTION
0278 PROTHROMBINASE EXPRESSION IN THE PREGNANT RAT UTERUS
0279 THE INTRAUTERINE EXPRESSION OF PROTHROMBIN
0280 A DEVELOPMENTAL ANALYSIS OF CELLULAR LOCALIZATION OF ERYTHROPOIETIN mRNA, PROTEIN, AND RECEPTOR IN THE OVINE PLACENTA
0281 GENE EXPRESSION OF AQUAPORIN 8 IN HUMAN CHORIOAMNIOTIC MEMBRANES: CELLULAR AND MOLECULAR MECHANISM OF INTRAMEMBRANOUS AMNIOTIC FLUID RESORPTION
0282 NONINVASIVE MEASUREMENT OF CERVICAL COLLAGEN IN WOMEN IN ACTIVE VERSUS LATENT LABOR AT TERM
0283 SYNCYTIAL KNOTS ARE THE SOURCE OF PLACENTAL CRH
0284 ENDOTHELIUM-DERIVED HYPERPOLARIZING FACTOR IN THE VASCULAR BED OF THE RAT UTERUS IN PREGNANCY
0285 CHOLINERGIC STIMULATION OF FETAL UPPER GASTROINTESTINAL MOTILITY
0286 TELEMETRIC CHARACTERIZATION OF THE ELECTRICAL PROPERTIES OF THE UTERUS DURING GESTATION AND PARTURITION IN CONSCIOUS, UNRESTRAINED RATS
0287 CHANGES IN BLADDER PRESSURE AND ELECTRICAL ACTIVITY DURING PREGNANCY IN CONSCIOUS, UNRESTRAINED RATS
0288 DISTINCT EXPRESSION LEVELS OF PROSTAGLANDIN E2 IN FETAL AND MATERNAL COMPARTMENT IN NORMAL TERM HUMAN PLACENTA
0289 UTERINE ACTIVITY DURING PREGNANCY: SINGLETON VERSUS TWIN GESTATIONS
0290 THE EFFECT OF AN ELEVATED MATERNAL LYSINE CONCENTRATION ON LYSINE TRANSPORT AND CATABOLISM IN THE OVINE MODEL
0291 EFFECT OF CRYOPRESERVATION ON UMBILICAL CORD STEM CELLS: PERCENT CD34+ AND VIABILITY IN TERM AND PRETERM CORD BLOOD AFTER FREEZING
0292 OPTIMAL PROCESSING OF UMBILICAL CORD BLOOD FOR RETRIEVAL OF WHITE BLOOD: A COMPARISON OF METHODS
0293 β2-MICROGLOBULIN LEVELS: A POTENTIAL MARKER OF FETOMATERNAL HISTOCOMPATIBILITY
0294 TENSILE STRENGTH OF THE CHORIOAMNION THROUGHOUT GESTATION
0295 THE EFFECTS OF ORTHOSTATIC CHANGES ON MATERNAL DIASTOLIC FILLING PATTERNS
0296 CONTRACTILE ACTIVITY OF OVINE FETAL COLON: MECHANISM FOR MECONIUM PASSAGE
0297 ORAL MAGNESIUM DOES NOT ALTER BRAIN LEVELS OF IONIZED MAGNESIUM IN PREGNANT RATS
0298 ANGIOTENSINOGEN T235 IS ASSOCIATED WITH ABNORMAL SPIRAL ARTERIES IN TERM MORPHOLOGY
0299 ANGIOTENSINOGEN T235 RELATED TO ABNORMAL SPIRAL ARTERY REMODELING IN THE SECOND TRIMESTER
300 ELECTROMYOGRAPHY AS AN ALTERNATIVE TO TOCODYNANOMETRY FOR MONITORING PREGNANT PATIENTS
0301 INTRAVENOUS 1-DESAMINO-[8-D-ARGININE] VASOPRESSIN (DDAVP) WITH ORAL WATER LOADING DOES NOT AFFECT OVINE UTERINE ARTERY BLOOD FLOW (UABF)
0302 INFLUENCE OF POLYAROMATIC HYDROCARBON ON FOOD INTAKE AND FETAL WEIGHT
0303 METABOLIC ADAPTATION TO PLACENTAL DYSFUNCTION DURING LATE PREGNANCY: EARLY ORIGINS OF INSULIN RESISTANCE
0304 EFFECT OF MATERNAL ANEMIA AND/OR MALNUTRITION ON FETAL THYROID FUNCTION
0305 INTRAPARTUM FETAL PULSE OXIMETRY IN THE PRETERM FETUS: A PILOT STUDY
0306 THE SIGNIFICANCE OF FETAL HEART RATE MONITORING DURING THE SECOND STAGE OF LABOR
0307 THE INFLUENCE OF INCREASED INTRAVENOUS HYDRATION ON THE INCIDENCE OF NONREASSURING FETAL HEART RATE PATTERNS IN NULLIPAROUS LABOR
0308 ABNORMAL FETAL HEART RATE TRACING PATTERNS DURING THE FIRST STAGE OF LABOR: EFFECT ON PERINATAL OUTCOME
0309 INTRAPARTUM FETAL STIMULATION TESTS: A META-ANALYSIS
0310 EXTERNAL CEPHALIC VERSION: A SINGLE CENTER APPROACH
0311 NEONATAL REPERFUSION ACIDOSIS: DOES IT EXIST?
0312 PATHOLOGIC ACIDEMIA AT BIRTH: CORRELATION WITH INTRAPARTUM ELECTRONIC FETAL HEART RATE PATTERNS
0313 FETAL OUTCOMES ASSOCIATED WITH PREGNANCIES REQUIRING CRITICAL CARE OBSTETRICS
0314 PATTERNS OF FETAL GROWTH RESTRICTION IN TERM BRAIN-DAMAGED INFANTS CHARACTERIZED BY FETAL HEART RATE PATTERNS
0315 FETAL SCALP pH CHANGES DURING LABOR AND UMBILICAL ARTERY pH AT BIRTH
0316 PREGNANCY OUTCOMES WITH UNEXPLAINED SEVERE MIDTRIMESTER OLIGOHYDRAMNIOS
0317 PREDICTION OF AMNIOTIC FLUID VOLUME AND FETAL GROWTH IN TWIN-TWIN TRANSFUSION SYNDROME (TTTS)
0318 INFLUENCE OF ACUTE CIGARETTE SMOKING ON FETAL HEART RATE REACTIVITY
0319 DEFINING OLIGOHYDRAMNIOS: GESTATIONAL AGE–SPECIFIC PERCENTILES PREDICT POOR PERINATAL OUTCOME BETTER THAN AN ABSOLUTE VALUE
0320 AUDITORY EVOKED MAGNETIC RESPONSE IN THE HUMAN FETUS USING A NEWLY DEVELOPED 151-CHANNEL SENSOR ARRAY (SARA)
0321 THE EFFECT OF MATERNAL INTRAVENOUS HYDRATION ON AMNIOTIC FLUID VOLUME
0322 INTRAUTERINE GROWTH RESTRICTION IS UNCOMMON IN FETUSES WITH A SINGLE UMBILICAL ARTERY
0323 PROLONGATION OF PREGNANCY BY INHIBITION OF CYCLOOXYGENASE-2 IN THE RAT CERVIX WITH CELECOXIB
0324 IN SEVERE INTRAUTERINE GROWTH RESTRICTION (IUGR), DOPPLER DETERIORATES BEFORE BIOPHYSICAL PARAMETERS WORSEN
0325 LONGITUDINAL CHANGES OF ARTERIAL AND VENOUS DOPPLER IN FETUSES WITH INTRAUTERINE GROWTH RESTRICTION (IUGR)
0326 ANTEPARTUM FETAL HEART RATE PATTERN AT THRESHOLD OF VIABILITY
0327 THE EARLY DIASTOLIC NOTCH DEPTH IN UTERINE ARTERY VELOCIMETRY AND PERINATAL OUTCOME
0328 THE PREDICTION OF PREECLAMPSIA BASED ON EARLY DIASTOLIC NOTCH OF UTERINE ARTERY DOPPLER VELOCIMETRY
0329 TERBUTALINE SULFATE: EFFECTS ON THE FETAL HEART AT TERM
0330 VARIABILITY VS NST FOR FETAL ASSESSMENT
0331 OLIGOHYDRAMNIOS AND HEMODYNAMIC DETERIORATION ARE RELATED, IN COMPROMISED FETUSES WITH INTRAUTERINE GROWTH RESTRICTION (IUGR)
0332 FETAL SEGMENTARY PULMONARY ARTERY BLOOD FLOW IN WOMEN WITH PREGESTATIONAL DIABETES
0333 SERIAL ASSESSMENT OF AMNIOTIC FLUID INDEX IN HIGH-RISK PREGNANCIES: OPTIMAL INTERVAL BETWEEN TESTING
0334 CRITICAL REAPPRAISAL OF THE UTILITY OF SONOGRAPHIC FETAL HUMERUS LENGTH IN THE PREDICTION OF TRISOMY 21
0335 MEASUREMENT OF THE DEEPEST VERTICAL POCKET (DVP) OF AMNIOTIC FLUID USING GRAY-SCALE VERSUS COLOR DOPPLER ULTRASOUND
0336 ETHNICITY-SPECIFIC NORMS FOR FETAL HEART RATE IN EARLY GESTATION
0337 SEQUENTIAL CARDIAC, ARTERIAL, AND VENOUS HEMODYNAMIC CHANGES PRECEDING FETAL DEATH IN SEVERE UTEROPLACENTAL INSUFFICIENCY
0338 EFFECT OF ANTEPARTUM CORTICOSTEROIDS ON FETAL HEART NONSTRESS TESTING
0339 AMNIOTIC FLUID EVALUATION AT 15-23 WEEKS GESTATION: ARE GROWTH-RESTRICTED FETUSES DIFFERENT?
0340 ABNORMAL UMBILICAL ARTERY VELOCIMETRY PREDICTS NEONATAL COMPLICATIONS IN PATIENTS WITH OLIGOHYDRAMNIOS AT TERM
0341 PREDICTING OF THE OUTCOME OF LABOR BY ANALYSIS OF FHR RECORDS OBTAINED WITHIN 7 DAYS OF DELIVERY USING CLASSIFICATION AND REGRESSION TREES
0342 AMNIOCENTESIS DOES NOT INCREASE THE RISK OF SPONTANEOUS ABORTION IN PATIENTS WITH LEIOMYOMATA UTERI
0343 GENETIC RISK ASSESSMENT: SHOULD PATIENTS ALWAYS BE REFERRED FOR GENETIC COUNSELING?
0344 ELEVATED AMNIOTIC FLUID FERRITIN LEVELS ARE ASSOCIATED WITH INFLAMMATION RELATED PREGNANCY LOSS FOLLOWING MIDTRIMESTER AMNIOCENTESIS
0345 GENETIC DRIFT BETWEEN TWO OUTBRED RAT COLONIES: A MODEL OF FETAL PROGRAMMING IN UTERO RESULTING IN SIGNIFICANT DIFFERENCES IN FETAL GROWTH
0346 CHANGES OVER TIME IN THE MODE OF CONCEPTION FOR PATIENTS UNDERGOING MULTIFETAL PREGNANCY REDUCTION
0347 NEW ESTIMATES FOR THE EFFICACY OF SECOND-TRIMESTER SERUM SCREENING FOR DOWN SYNDROME AND TRISOMY 18; ADJUSTMENT FOR CROSS-IDENTIFICATION AND DOUBLE-POSITIVE RESULTS
0348 ASSESSMENT OF POTENTIAL DEMAND FOR INVASIVE GENETIC TESTING USING WILLINGNESS TO PAY
0349 MATERNAL AND FETAL INHERITED THROMBOPHILIAS AND PRETERM BIRTH
0350 UTILITY ASSESSMENT OF AMNIOCENTESIS: IS 35 YEARS A RATIONAL CUTOFF?
0351 TROPHOBLAST INCLUSIONS ARE ASSOCIATED WITH KARYOTYPIC ABNORMALITIES
0352 MODEL FOR THE FORMATION OF TROPHOBLAST INCLUSIONS IN CHORIONIC VILLI
0353 CHORIONIC VILLUS SAMPLING (CVS): THE PREFERRED PRENATAL DIAGNOSTIC PROCEDURE FOR TWIN PREGNANCIES
0354 CHORIONIC VILLUS SAMPLING PRIOR TO MULTIFETAL PREGNANCY REDUCTION: ACCURACY AND SUCCESS
0355 PATIENT-SPECIFIC TRISOMY 18 RISK BASED ON ULTRASOUND AND AGE
0356 COMBINED BIOCHEMICAL AND SONOGRAPHIC FIRST-TRIMESTER SCREENING FOR DOWN SYNDROME AND OTHER CHROMOSOME ANOMALIES
0357 FETAL GENDER: DIFFERENCES BETWEEN BIOCHEMICAL AND BIOPHYSICAL PARAMETERS IN FETUSES WITH TRISOMY 21
0358 VARIATION IN POPULATION DISTRIBUTION AND ITS IMPACT ON LIKELIHOOD RATIOS FOR DOWN SYNDROME SCREENING
0359 MATERNAL WEIGHT CORRECTION FOR ALPHA FETOPROTEIN: MATHEMATICAL TRUNCATIONS REVISITED
0360 STANDARDIZATION OF METHODS REDUCES VARIABILITY: EXPLANATION FOR THE WIDE HISTORICAL DISCREPANCY AMONG BIOCHEMICAL SCREENING RESULTS
0361 A COST-EFFECTIVENESS ANALYSIS OF FETAL DOWN SYNDROME SCREENING: FIRST VERSUS SECOND TRIMESTER
0362 FETAL KARYOTYPING IN TWINS; DOES DUAL AMNIOCENTESIS MAKE SENSE? A REVIEW OF 20 YEARS’ EXPERIENCE
0363 CAN ULTRASOUND RELIABLY REDATE PREGNANCY IN WOMEN AT RISK FOR TRISOMY 21 BASED ON A MATERNAL SERUM TRIPLE SCREEN?
0364 PREGNANCY OUTCOME OF WOMEN WITH EXTREMELY LOW LEVELS OF MATERNAL SERUM UNCONJUGATED ESTRIOL ON SECOND-TRIMESTER SCREENING
0365 CYTOGENETIC ABNORMALITIES AND PARENTAL DECISION: INFLUENCE OF GESTATIONAL AGE AT DIAGNOSIS
0366 SECOND-TRIMESTER MATERNAL SERUM TRIPLE MARKER LEVELS IN WOMEN WITH THREATENED ABORTION
0367 EFFECTS OF ANEUPLOIDY ON STEROIDOGENESIS IN THE FIRST TRIMESTER
0368 WOMEN AT GENETIC RISK WHO CHANGE THEIR ATTITUDE TOWARDS AMNIOCENTESIS AFTER ULTRASONOGRAPHIC EXAMINATION: WHAT FACTORS ARE INVOLVED?
0369 MATERNAL SERUM SCREENING IN PREGNANCIES RESULTING FROM OOCYTE DONATION
0370 ANALYSIS OF HUMAN CD34+ CELLS FOR CO-EXPRESSION OF KDR, CD34, CD38, AND AC133
0371 THERE IS NO ASSOCIATION BETWEEN FETAL LOSS RATE AFTER CVS AND MATERNAL Rh STATUS
0372 CERVICAL DILATION AT FIRST ASSESSMENT IN LABOUR AS A PREDICTOR OF OBSTETRIC OUTCOME
0373 ACTIVE MANAGEMENT OF LABOR IN MULTIPAROUS WOMEN
0374 CHARACTERIZATION OF CARDIOTOCOGRAPHIC ABNORMALITIES ASSOCIATED WITH DINOPROSTONE AND MISOPROSTOL CERVICAL RIPENING/LABOR INDUCTION
0375 ANAL SPHINCTER DISRUPTION AT VAGINAL DELIVERY: IS RECURRENCE PREDICTABLE?
0376 ACTIVE PHASE LABOR ARREST: BEYOND THE 2-HOUR MINIMUM
0377 LABOR INDUCTION IN WOMEN WITH ONE PRIOR LOW TRANSVERSE C-SECTION
0378 OUTPATIENT CERVICAL RIPENING WITH ORAL MISOPROSTOL POSTTERM: INDUCTION RATES DECREASED
0379 RELATIONSHIP BETWEEN POSTPARTUM FECAL INCONTINENCE SYMPTOMS AND ANAL ENDOSONOGRAPHIC FINDINGS
0380 THE USE OF OXYTOCIN FOR LABOR AUGMENTATION IN POSTCESAREAN SECTION WOMEN: IS IT REALLY SAFE?
0381 RIPENING OF UTERINE CERVIX IN A POST CESAREAN SECTION PARTURIENT: PGE2 vs. INTRACERVICAL FOLEY CATHETER
0382 RELATIONSHIP BETWEEN COX-2 AND INOS IN THE RAT CERVIX DURING PREGNANCY, LABOR, AND POSTPARTUM
0383 INCIDENCE AND CHARACTERISTICS OF MATERNAL CARDIAC ARRHYTHMIAS DURING LABOR
0384 ORAL VERSUS VAGINAL MISOPROSTOL FOR INDUCTION OF LABOUR: A DOUBLE-BLIND, PLACEBO-CONTROLLED RANDOMISED TRIAL
0385 A RANDOMIZED CLINICAL TRIAL COMPARING MISOPROSTOL SUPPOSITORIES WITH CONTINUOUS DINOPROSTONE FOR CERVICAL RIPENING AND LABOR INDUCTION
0386 IS THERE AN IDEAL ROUTE OF MISOPROSTOL ADMINISTRATION FOR CERVICAL RIPENING AND LABOR INDUCTION?
0387 RISK OF COMPLICATIONS ASSOCIATED WITH MEDICAL MIDTRIMESTER PREGNANCY TERMINATION AMONG WOMEN WITH A PREVIOUS CESAREAN BIRTH
0388 RANDOMIZED TRIAL OF CONCURRENT OXYTOCIN AND SUSTAINED-RELEASE DINOPROSTONE FOR LABOR INDUCTION
0389 THE ASSOCIATION BETWEEN HUMAN LEUKOCYTE ANTIGEN (HLA)-G EXPRESSION AND PARTURITION
0390 A RANDOMIZED TRIAL OF THE MANAGEMENT OF THE SECOND STAGE OF LABOR IN NULLIPAROUS PATIENTS WITH CONTINUOUS EPIDURAL ANALGESIA
0391 A PROSPECTIVE STUDY OF NUCHAL CORD AT BIRTH
0392 OXYTOCIN EFFECT ON CONTRACTION OF ISOLATED UTERUS, CERVIX AND VAGINA FROM PREGNANT RATS
0393 FIRST MAGNETOMYOGRAPHIC RECORDINGS OF UTERINE ACTIVITY WITH SPATIAL-TEMPORAL INFORMATION USING A 151-CHANNEL SENSOR ARRAY (SARA)
0394 RECTAL MISOPROSTOL VERSUS OXYTOCIN FOR PREVENTION OF POSTPARTUM HEMORRHAGE FOLLOWING VAGINAL DELIVERY
0395 RAPID RISING IN INDUCTION OF LABOR AND ITS ASSOCIATION WITH CESAREAN DELIVERY IN THE US
0396 VAGINALLY ADMINISTERED MISOPROSTOL FOR OUTPATIENT LABOR INDUCTION IN PREGNANCIES WITH DIABETES MELLITUS
0397 ARE WOMEN WHO ARE JEHOVAH’S WITNESSES AT RISK OF MATERNAL MORTALITY?
0398 EFFECT OF ENDOGENOUS MAST CELL DEGRANULATION ON UTERINE AND CERVICAL CONTRACTILITY IN PREGNANT 5-LIPOXYGENASE-KNOCKOUT MICE
0399 LIGHT-INDUCED FLUORESCENCE OF CERVICAL COLLAGEN DECREASES IN LABOR AT TERM AND PRETERM COMPARED TO NONLABORING PREGNANT WOMEN
0400 CERVICAL RIPENING IN PREGNANT RATS IS PREVENTED BY NITRIC OXIDE SYNTHASE AND CYLOXYGENASE INHIBITION
0401 DOES MALPOSITION OF THE FETUS IN LABOR PREDISPOSE TO OCCIPUT POSTERIOR POSITION AT DELIVERY?
0402 EVALUATION OF DELAYED INTERLEUKIN-10 TOCOLYTIC THERAPY IN A RAT MODEL OF ENDOTOXIN-INDUCED PRETERM LABOR
0403 ELEVATION OF TNF-αAND IL-6 PRODUCTION BY NORMAL TERM HUMAN PLACENTAE AFTER STIMULATION WITH LIPOPOLYSACCHARIDE
0404 THE NOVATRIX LABOR ASSISTER SYSTEM IS AN EFFECTIVE MEANS OF INCREASING INTRAUTERINE PRESSURE DURING THE SECOND STAGE OF LABOR IN PATIENTS WITH EPIDURAL ANALGESIA
0405 INTRAUTERINE ENDOTOXIN INFUSION IN PREGNANT RATS INCREASES AMNIOTIC MEMBRANE, UTERINE AND PLACENTAL LEVELS OF TUMOR NECROSIS FACTOR-α
0406 EFFECTS OF McROBERTS MANEUVER ON INTRAUTERINE PRESSURE DURING THE SECOND STAGE OF LABOR
0407 THE VALSALVA INDEX: A NOVEL APPROACH FOR ESTIMATING PUSHING EFFICACY IN PATIENTS WITH EPIDURAL ANESTHESIA
0408 UTERINE CONTRACTION PRESSURES (INTRAUTERINE PRESSURE) IN ACTIVELY PUSHING WOMEN DURING THE SECOND STAGE OF LABOR
0409 DOSAGE VARIATION ASSOCIATED WITH 25 μ g MISOPROSTOL ADMINISTRATION
0410 PRODUCTION OF PERITONEAL FLUID RICH IN IL-6 AND sIL-2R IN OBSTRUCTED LABOR
0411 DIFFERENCES IN CERVICAL DILATION AND INDUCTION IN PATIENTS DELIVERED BECAUSE OF DYSTOCIA DURING A MULTICENTER RANDOMIZED CLINICAL TRIAL OF FETAL PULSE OXIMETRY
0412 SHOULDER DYSTOCIA–ASSOCIATED BRACHIAL PLEXUS INJURY: DO ANTEPARTUM OR INTRAPARTUM CHARACTERISTICS PREDICT PERMANENCE OF INJURY?
413 CHANGES IN UTERINE ELECTRICAL ACTIVITY ASSESSED BY TRANSABDOMINAL ELECTROMYOGRAPHY
0414 INDUCTION OF LABOR WITH MISOPROSTOL IN PATIENTS WITH PREVIOUS CESAREAN SECTION: RISK FACTORS FOR THE DEVELOPMENT OF UTERINE RUPTURE
0415 MISOPROSTOL FOR THIRD TRIMESTER LABOR INDUCTION: A SURVEY OF LABOR INDUCTION METHODS
0416 EXTRA-AMNIOTIC FOLEY BULB PLACEMENT WITH OR WITHOUT CONCURRENT ADMINISTRATION OF OXYTOCIN FOR INDUCTION OF LABOR
0417 PHARMACOLOGIC INDUCTION OF CERVICAL RIPENING BY SYSTEMIC DHEA-S ADMINISTRATION IN POST-TERM PREGNANCY
0418 α1-ANTITRYPSIN SERUM ELEVATION MATCHED TO NEUTROPHIL POLYMORPHONUCLEAR LEUKOCYTE COUNT AS A MARKER OF UTERINE CONTRACTILITY
0419 DEFINING THE RELATIONSHIP BETWEEN OBSTETRICIANS AND MATERNAL-FETAL MEDICINE SPECIALISTS
0420 ATTITUDES OF MATERNAL-FETAL SPECIALISTS CONCERNING MATERNAL-FETAL SURGERY
0421 HAVE THE RECENT CHANGES IN THE STRUCTURE AND CONTENT OF MATERNAL-FETAL MEDICINE FELLOWSHIPS CHANGED FELLOWSHIP EXPERIENCE?
0422 TRENDS AND FACTORS ASSOCIATED WITH MATERNAL-FETAL MEDICINE FELLOWSHIP SELECTION; HOW DO SELECTION CRITERIA AFFECT FELLOWSHIP EXPERIENCE?
0423 Withdrawn
0424 OBSTETRICAL PATIENTS’ SATISFACTION WITH CARE: ATTENTION FROM DOCTORS AND NURSES MAKES THE DIFFERENCE
0425 ANTENATAL STEROIDS AND NEONATAL PERIVENTRICULAR LEUCOMALACIA
0426 UTEROPLACENTAL INSUFFICIENCY: DOES THE PRESENCE OF ASSOCIATED VILLOUS LESIONS MAKE A DIFFERENCE?
0427 DOES AMNIOTIC FLUID VOLUME INTERFERE WITH THE INTERPRETATION OF FETAL LUNG MATURITY STUDIES?
0428 THE EFFECTS OF HYPOXIA AND HYPEROXIA ON FETAL-PLACENTAL VASCULAR TONE AND INFLAMMATORY CYTOKINE PRODUCTION
0429 FACTOR V LEIDEN AND PROTHROMBIN 20210 G-A MUTATIONS IN ASSOCIATION WITH SEVERELY GROWTH RESTRICTED PREGNANCIES
0430 FETAL OPEN SPINA BIFIDA: IN UTERO NATURAL HISTORY
0431 THE ASSOCIATION OF ABNORMAL FETAL HEART RATE PATTERNS WITH NUCLEATED RED BLOOD CELLS
0432 EFFECTS OF CENTRAL ANGIOTENSIN-II RECEPTOR ANTAGONISM ON FETAL SWALLOWING
0433 ELEVATED URINARY INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN-3 PREDICTS RENAL OUTCOME IN FETUSES WITH LOWER URINARY TRACT OBSTRUCTION
0434 SHORT-TERM OUTCOMES IN FETAL MENINGOMYELOCELE REPAIR
0435 INTRAUTERINE TRANSFUSION THERAPY FOR FETAL HOMOZYGOUS α-THALASSEMIA
0436 THE VALUE OF SERIAL ANTIBODY TITER ASSESSMENT IN KELL ALLOIMMUNIZED PREGNANCIES
0437 FETOSCOPIC TAIL DOCKING IN THE LAMB: A MODEL FOR REMOVING SOLID TUMORS USING THE HARMONIC SCALPEL DURING FETAL LIFE
0438 EFFECT OF MILD CHRONIC HYPOXIA ON LATE GESTATION FETAL SHEEP PHYSIOLOGIC RESPONSES
0439 PREVALENCE OF ORGAN SYSTEM INJURY IN ACUTE BIRTH ASPHYXIA
0440 THE EFFECT OF ANTENATAL STEROID THERAPY ON BIRTH WEIGHT
0441 THE ABSENCE OF FETAL HEART RATE ACCELERATIONS PREDICTS ELEVATED NUCLEATED RED BLOOD CELLS
0442 LARGE FETAL SACROCOCCYGEAL TERATOMAS: COULD EARLY DELIVERY IMPROVE OUTCOME?
0443 QUANTITATIVE CALCULATION OF NUCLEATED RED CELL CONCENTRATION FROM PLACENTAL HISTOLOGIC SECTIONS PREDICTS NEWBORN NUCLEATED RED CELL CONCENTRATION
0444 CESAREAN SECTION DOES NOT IMPROVE NEONATAL OUTCOME IN FETUSES WITH ABDOMINAL WALL DEFECTS
0445 ANALYSIS OF THROMBOPHILIC POLYMORPHISMS IN ASSOCIATION WITH GASTROSCHISIS
0446 THROMBOEMBOLIC MUTATIONS IN NEONATES WITH GASTROSCHISIS: A POSSIBLE ETIOLOGY?
0447 MATERNALLY DERIVED PLATELET/PLASMA TRANSFUSIONS CAUSE TRANSIENT THROMBOCYTOPENIA IN THE FETAL LAMB MODEL
0448 FETAL MACROSOMIA (≥4500 g): PERINATAL OUTCOME OF 231 CASES
0449 ADAPTATION OF CORE BIOPSY NEEDLE DEVICE FOR FETAL SKIN SAMPLING
0450 INFLUENCE OF BODY MASS INDEX ON PREGNANCY LOSS RATES FOLLOWING MULTIFETAL PREGNANCY REDUCTION
0451 PRENATAL DIAGNOSIS OF CONGENITAL HEART DISEASE AND INTRAUTERINE FETAL GROWTH RESTRICTION
0452 INTRAUTERINE GROWTH RESTRICTED INFANTS <1000 GRAMS ARE AT HIGHER RISK OF NECROTIZING ENTEROCOLITIS AND NEONATAL DEATH COMPARED WITH APPROPRIATELY GROWN INFANTS OF SIMILAR WEIGHT
0453 MATERNAL AND FETAL THROMBOPHILIA IN COMPLICATED PREGNANCIES
0454 NITROUS OXIDE AMNIODISTENTION REDUCES OPERATION TIME COMPARED WITH FLUID AMNIODISTENTION WITHOUT CHANGES IN FETAL ACID-BASE STATUS IN A SHEEP MODEL FOR FETOSCOPIC SURGERY
0455 GASTROSCHISIS: THE EFFECT OF LABOR AND RUPTURED MEMBRANES ON NEONATAL OUTCOME
0456 PERINATAL OUTCOME OF TWIN GESTATIONS WITH A STRUCTURALLY AFFECTED TWIN: A CASE-CONTROL STUDY
0457 BONDING AND COPING WITH LOSS: EXAMINING THE CONSTRUCTION OF AN INTERVENTION FOR MULTIFETAL PREGNANCY REDUCTION PROCEDURES
0458 CORRELATION OF TRACHEAL DIAMETER MEASURED BY ULTRASOUND AND NECROPSY FINDINGS IN HUMAN FETUSES
0459 IS THE AMNIOTIC FLUID LAMELLAR BODY COUNT A RELIABLE PREDICTOR OF FETAL LUNG MATURITY IN WOMEN WITH PREMATURE RUPTURE OF MEMBRANES?
0460 EFFECTS OF INTRAPARTUM MAGNESIUM SULFATE THERAPY ON FETAL ADRENAL FUNCTION: A RANDOMIZED, PLACEBO-CONTROLLED TRIAL
0461 CONGENITAL ANOMALIES DIAGNOSED BY ULTRASOUND PRIOR TO 24 WEEKS: HOW FUTURE RISK OF HANDICAP AFFECTS PARENTAL DECISION
0462 HUMAN FETAL BRAIN METABOLITES DETECTED WITH PROTON MAGNETIC RESONANCE SPECTROSCOPY
0463 SECOND-TRIMESTER UMBILICAL CORD OCCLUSION USING ULTRASOUND DIRECTED BIPOLAR COAGULATION FOR SELECTIVE TERMINATION IN COMPLICATED MONOCHORIONIC TWIN GESTATIONS
0464 INCREASED UMBILICAL VEIN FLOW AND TRANSIENT RIGHT HEART FAILURE IN DONOR FETUSES FROM SEVERE TWIN-TWIN TRANSFUSION SYNDROME AFTER LASER COAGULATION: VENOUS OVERLOAD SUGGESTING SUCCESSFUL TREATMENT
0465 IMPACT OF COUNSELING ON RATES OF AMNIOCENTESIS AND DETECTION OF TRISOMY 21 IN CONTEXT OF PERINATAL CONSULTATION
0466 THE IMPACT OF HYPERHOMOCYSTEINEMIA ON CONGENITAL ANOMALIES
0467 NEUTROPHIL COLLAGENASE (MMP-8): AN INDEX OF THE FETAL INFLAMMATORY RESPONSE SYNDROME
0468 REPAIR OF MYELOMENINGOCELE IN UTERO I: EXPERIMENTAL PATHOPHYSIOLOGY, NATURAL HISTORY, AND INITIAL UCSF CLINICAL EXPERIENCE
0469 AMNIOTIC FLUID LAMELLAR BODY COUNT IN THE PREDICTION OF FETAL LUNG MATURITY
0470 LESSONS FROM AN IN VITRO MODEL TO PLUG MEMBRANE DEFECTS UTILIZING GELATIN SPONGE: RATIONALE FOR THE EMBOLIZATION PROCEDURE
0471 MATERNAL OUTCOMES FOLLOWING THE EXIT PROCEDURE AS COMPARED WITH STANDARD CESAREAN SECTION
0472 IMMUNOLOGICAL FUNCTION OF THE HUMAN FETUS
0473 WHICH FACTORS CONDITION A DECISION TOWARD AMNIOCENTESIS IN WOMEN UNDECIDED PRIOR TO GENETIC COUNSELING AND ULTRASONOGRAPHY?
0474 EFFECTS OF ULTRASONOGRAPHIC FINDINGS ON THE CHANGE OF ATTITUDE TOWARD AMNIOCENTESIS IN WOMEN 35 YEARS OF AGE OR OLDER
0475 PERIPARTAL CHANGES IN NONENZYMATIC ANTIOXIDANT RESERVE (NAR) OF HUMAN FETUSES
0476 FDA PREGNANCY CATEGORY LABELING OF SYSTEMIC ANTI-INFECTIVES LISTED IN THE 2000 PHYSICIANS’ DESK REFERENCE (PDR)
0477 FDA PREGNANCY CATEGORY LABELING OF DIETARY SUPPLEMENTS LISTED IN THE US PDR 2000
0478 CHORIOAMNIOTIC MEMBRANE SEPARATION FOLLOWING FETAL SURGERY
0479 SELECTIVE TERMINATION OF ACARDIAC/ACEPHALIC TWIN BY RADIOFREQUENCY ABLATION
0480 INTRAUTERINE REPAIR OF SPINA BIFIDA: IDENTIFICATION OF A GOOD PROGNOSIS GROUP
0481 AMNIOTIC FLUID VOLUME AND INTRAMEMBRANOUS PERMEABILITY CHANGES DURING LONG-TERM INTRAVASCULAR INFUSION OF SALINE IN THE OVINE FETUS
0482 FOLIC ACID FORTIFICATION: A POPULATION-BASED STUDY OF ITS EFFECT ON THE INCIDENCE OF OPEN NEURAL TUBE DEFECTS (ONTDs)
0483 OSMOLALITY AND ONCOTIC PRESSURE DO NOT APPEAR TO INFLUENCE AMNIOTIC FLUID EQUALIZATION AFTER SEPTOSTOMY IN PREGNANCIES COMPLICATED BY TWIN-TWIN TRANSFUSION SYNDROME
0484 COMPARATIVE LONGITUDINAL STUDY OF CERVICAL LENGTH BETWEEN SINGLETON, TWIN, AND TRIPLET PREGNANCIES
0485 IS AN ISOLATED FETAL CARDIAC ECHOGENIC FOCUS AN INDICATION FOR FETAL ECHOCARDIOGRAPHY?
0486 DETECTION OF ANEUPLOIDY USING FIRST-TRIMESTER NUCHAL TRANSLUCENCY THICKNESS: A META-ANALYSIS
0487 DO MATERNAL WEIGHT AND SONOGRAPHIC FACTORS INFLUENCE THE ANTENATAL DETECTION OF A FETAL ECHOGENIC CARDIAC FOCUS?
0488 EFFICACY OF TEN ULTRASOUND SCREENING MARKERS FOR DOWN SYNDROME
0489 EFFICACY OF STRUCTURAL CARDIAC DEFECTS AS MARKERS FOR DOWN SYNDROME IN A COMMUNITY TEACHING HOSPITAL
0490 CLINICAL SIGNIFICANCE OF MILD VENTRICULOMEGALY AND CHOROIDAL SEPARATION IDENTIFIED ANTENATALLY
0491 THREE-DIMENSIONAL TRANSVAGINAL ULTRASOUND OF THE CERVIX: ITS ROLE IN PREDICTING PRETERM DELIVERY
0492 OPTIMAL TIMING OF SECOND-TRIMESTER OBSTETRICAL ULTRASOUND BASED ON MATERNAL BODY MASS INDEX
0493 TARGETED ULTRASOUND AFTER AN ABNORMAL KARYOTYPE: THE PATIENT’S PERSPECTIVE
0494 THE RELATIONSHIP BETWEEN SONOGRAPHIC FINDINGS AND DEGREE OF ELEVATED MATERNAL SERUM α-FETOPROTEIN
0495 THE DIAGNOSTIC ACCURACY OF FETAL ECHOCARDIOGRAPHY IN A SPECIALIZED FETAL CARDIOVASCULAR UNIT
0496 THE CLINICAL SIGNIFICANCE OF ISOLATED FETAL ECHOGENIC BOWEL
0497 FACTORS ASSOCIATED WITH FETAL DEMISE IN ISOLATED FETAL ECHOGENIC BOWEL
0498 RELATIONSHIP BETWEEN DEEPEST VERTICAL AMNIOTIC FLUID POCKET AND BIRTH WEIGHT IN TERM PATIENTS WITH INTACT MEMBRANES
0499 HUMERAL SOFT TISSUE THICKNESS AS A PREDICTOR OF FETAL GROWTH RESTRICTION
0500 ANTENATAL DIAGNOSIS OF SINGLE UMBILICAL ARTERY: IS FETAL ECHOCARDIOGRAPHY NECESSARY?
0501 SEPTOSTOMY VERSUS AMNIOREDUCTION IN TWIN-TWIN TRANSFUSION SYNDROME
0502 CHOROID PLEXUS CYSTS: ASSESSMENT OF TRISOMY 18 RISK USING ULTRASOUND AND BIOCHEMICAL MARKERS
0503 REPRODUCIBILITY STUDY OF A NEW SONOGRAPHIC TECHNIQUE FOR SUBCUTANEOUS TISSUE ASSESSMENT OF THE HUMAN FETUS.
0504 ULTRASOUND EVALUATION OF FETAL CEREBELLAR DEVELOPMENT
0505 ACCURACY OF ULTRASOUND AND CLINICAL INTRAPARTUM FETAL WEIGHT ESTIMATION (EFW) IN A GENERAL POPULATION
0506 RELATIONSHIP BETWEEN THE AMOUNT OF WHARTON’S JELLY IN UTERO AND THE AMNIOTIC FLUID AND FETAL BLOOD OSMOLALITY
0507 PRENATAL SONOGRAPHIC DIAGNOSIS OF NUCHAL CORD
0508 ALTITUDE REDUCES SUBCUTANEOUS MASS BUT NOT LEAN MASS IN NORMAL FETUSES
0509 THE USE OF NEONATAL ANTHROPOMETRIC MEASUREMENTS TO PREDICT BIRTH WEIGHT BY ULTRASOUND
0510 PRENATAL PREDICTION OF SIGNIFICANT MORBIDITY RELATED TO GROWTH RESTRICTION: A PROSPECTIVE STUDY
0511 CERVICAL LENGTH MEASUREMENTS IN PREGNANCY ARE LONGER WHEN MEASURED WITH 3-DIMENSIONAL TRANSVAGINAL ULTRASOUND
0512 ACCURACY OF ULTRASOUND-DETERMINED ESTIMATED FETAL WEIGHT IN FETUSES WITH GASTROSCHISIS
0513 PRIOR CONE BIOPSY: PREDICTION OF PRETERM DELIVERY IN SUBSEQUENT PREGNANCY BY TRANSVAGINAL ULTRASOUND OF THE CERVIX
0514 EARLY DETECTION OF FETAL CARDIAC ANOMALIES
0515 FETAL BLADDER SAGITTAL LENGTH (FBSL): A SIMPLE ASSESSMENT OF FETAL BLADDER SIZE: NORMAL OR OBSTRUCTED.
0516 THE IMPACT OF THE USE OF ECHOGENIC INTRACARDIAC FOCUS AS A SCREEN FOR TRISOMY 21 IN WOMEN UNDER THE AGE OF 35
0517 CERVICAL LENGTH ≤ 25 MM IS ASSOCIATED WITH HIGHER RATES OF POSITIVE FETAL LUNG MATURITY AMONG PATIENTS WITH PRETERM LABOR
0518 ADMISSION TO DELIVERY INTERVAL, CEREBRAL BLOOD FLOW REDISTRIBUTION, AND CERVICAL LENGTH IN PATIENTS WITH PRETERM LABOR
0519 IMPACT OF ANTENATAL STEROIDS ON MATERNAL AND FETAL BLOOD FLOW VELOCIMETRY IN PATIENTS WITH PRETERM LABOR: A PROSPECTIVE STUDY
0520 PRENATAL ULTRASOUND AND THE DIAGNOSIS OF FETAL CLEFT LIP
0521 THE CLINICAL SIGNIFICANCE, PERINATAL AND NEONATAL OUTCOME OF FETUSES WITH LATERAL VENTRICLE ATRIA BETWEEN 8 AND 10 MM.
0522 THREE-DIMENSIONAL COLOR AND POWER DOPPLER ULTRASOUND PROVIDES IMPROVED CERTAINTY OF DIAGNOSIS OF VASA PREVIA
0523 ASSESSMENT OF FETAL ECHOCARDIOGRAPHY AT 11 TO 13 WEEKS OF GESTATION
0524 CERVICAL LENGTH AFTER MULTI-FETAL PREGNANCY REDUCTION IN REMAINING TWIN GESTATIONS
0525 THE ROLE OF PRENATAL ULTRASOUND IN PREDICTING FUNCTIONAL DISABILITIES IN INFANTS WITH MYELOMENINGOCELE
0526 THE VALUE OF FIRST-TRIMESTER NUCHAL TRANSLUCENCY MEASUREMENTS IN CHANGING RISKS FOR DOWN SYNDROME
0527 EVALUATION OF THIRD-TRIMESTER LUNG TO HEAD RATIO AS A PREDICTOR OF OUTCOME IN CONGENITAL DIAPHRAGMATIC HERNIA
0528 ANTENATAL HYDRONEPHROSIS IS A SIGN OF NEONATAL VESICOURETERAL REFLUX
0529 SONOGRAPHICALLY DETECTED NUCHAL CORD: WHAT ABOUT IT?
0530 Withdrawn
0531 PREDICTORS OF OUTCOME IN PRENATALLY DIAGNOSED GASTROSCHISIS
0532 FETAL PULMONARY ARTERY DIAMETERS AND DOPPLER INDICES STANDARDIZED FOR FETAL BIOMETRIC PARAMETERS
0533 THE CONTRIBUTION OF MATERNAL BODY MASS INDEX AND GESTATIONAL AGE TO THE DETECTION OF FETAL ANOMALIES
0534 PERFUSION PRESSURE, NOT CEREBRAL BLOOD FLOW, IS THE CRITICAL DETERMINANT OF CEREBRAL INJURY IN PREECLAMPSIA
0535 CEREBRAL PERFUSION PRESSURE IS NOT EQUAL ON BOTH SIDES OF THE BRAIN IN PREECLAMPSIA
0536 PELVIC BLOOD FLOW IN EARLY PREGNANCY: COLOR VS. POWER DOPPLER
0537 DOPPLER IN THE ANTENATAL PREDICTION OF INTRAVENTRICULAR HEMORRHAGE IN FETAL GROWTH RESTRICTION
0538 CHANGES IN THE ATRIAL CONTRACTION COMPONENT OF THE PULMONARY VEIN DOPPLER WAVE FORM IN ANEMIC FETUSES
0539 AORTIC ISTHMUS BLOOD FLOW AND DISTRIBUTION OF CARDIAC OUTPUT IN GROWTH RESTRICTED FETUSES
0540 VENTRICULAR FILLING PATTERNS AND AORTIC ISTHMUS BLOOD FLOW IN GROWTH RESTRICTED FETUSES
0541 AORTIC ISTHMUS HEMODYNAMICS AND CENTRALIZATION OF BLOOD FLOW IN GROWTH RESTRICTED HUMAN FETUSES
0542 INCREASED RESPONSE OF THE MATERNAL MIDDLE CEREBRAL ARTERY TO 2% CO2 ADMINISTRATION DURING PREGNANCY AND POSTPARTUM
0543 PERSISTENT REDUCTION IN UMBILICAL VEIN FLOW VELOCITY IN THE GROWTH RESTRICTED FETUS: A LONGITUDINAL STUDY
0544 MCA DOPPLER PEAK SYSTOLIC VELOCITY PREDICTS ANEMIA IN FETAL PARVOVIRUS INFECTION
0545 VASCULAR REACTIVITY IN THE PREGNANT AND NONPREGNANT PATIENT
0546 ANTENATAL FETAL RISK ASSESSMENT BY BLOOD FLOW VELOCITY WAVEFORMS USING DISCRIMINANT FUNCTIONS: UMBILICAL ARTERY AND CEREBRAL-UMBILICAL RATIO
0547 HIGH VASCULAR RESISTENCE IN SPIRAL ARTERIES CAN PREDICT PLACENTAL DETACHMENT
0548 EPIDURAL ANALGESIA IS ASSOCIATED WITH AN INCREASED RISK OF REPEATED CESAREAN SECTION.
0549 EPIDURAL ANALGESIA IN TWIN GESTATION IS ASSOCIATED WITH ADVERSE OBSTETRICAL OUTCOME
0550 OBSTETRICAL RISK FACTORS AND PREGNANCY OUTCOME OF PLACENTA PREVIA
0551 CLINICAL RISK FACTORS AND PREGNANCY OUTCOME OF PRETERM PLACENTAL ABRUPTION
0552 INFERTILITY TREATMENT IS AN INDEPENDENT RISK FACTOR FOR CESAREAN SECTION AMONG NULLIPAROUS WOMEN AGED 40 AND OLDER
0553 FAILED VACUUM EXTRACTION: MATERNAL RISK FACTORS AND PREGNANCY OUTCOME
0554 FETAL HYDROFLOTATION: A NOVEL TECHNIQUE FOR FACILITATING EXTERNAL CEPHALIC VERSION
0555 INCREASED GESTATIONAL DURATION: RESULTS OF A RANDOMIZED CLINICAL TRIAL TO REDUCE ANTENATAL DRINKING
0556 PROSPECTIVE RANDOMIZED TRIAL OF ONCE VERSUS TWICE A DAY METRONIDAZOLE-VAGINAL IN OBSTETRICAL POPULATION IDENTIFIED WITH BACTERIAL VAGINOSIS
0557 PFANNESTIEL OR JOEL-COHEN INCISION AT CESAREAN DELIVERY: A RANDOMIZED CLINICAL TRIAL
0558 DOES A SINGLE PRENATAL CARE VISIT IMPROVE PERINATAL OUTCOMES?
0559 PATIENT PERCEPTIONS OF MULTIPLE GESTATIONS: AN ASSESSMENT OF KNOWLEDGE AND RISK AVERSION
0560 IS OBSTETRICS AND GYNECOLOGY SONOGRAPHY ESSENTIAL AT A FIELD HOSPITAL SETUP? THOUGHTS AFTER THE EARTHQUAKE—TURKEY, 1999
0561 CLINICAL IMPLICATIONS OF VELAMENTOUS CORD INSERTION IN TRIPLET GESTATIONS
0562 VBAC SCORE <4: SHOULD THEY LABOR?
0563 COMPARISON OF TRIPLET OUTCOMES MANAGED BY MATERNAL FETAL MEDICINE VERSUS COMMUNITY PHYSICIANS
0564 DOES PROLONGED PREGNANCY PREDICT ADVERSE PERINATAL OUTCOME?
0565 MALE GENDER IS AN ETIOLOGY FOR POSTDATES PREGNANCY
0566 SCREENING FOR TYPE; TRANSFUSIONS IN PREGNANCY
0567 THE PERINATAL AND ECONOMIC IMPACT OF PUBLIC FUNDING OF PRENATAL CARE
0568 TWIN DISCORDANCE WITH OR WITHOUT INTRAUTERINE GROWTH RESTRICTION (IUGR): PERINATAL OUTCOME
0569 TIMELY DETECTION OF UTERINE RUPTURE DURING VBAC
0570 PRENATAL DRUG EXPOSURE AND GROWTH TO AGE 7
0571 ANESTHESIA OPTIONS FOR TRIPLET DELIVERIES
0572 COMPARISON OF CERVICAL COLLAGEN IN WOMEN WITH INCOMPETENT CERVIX VERSUS WOMEN WITH COMPETENT CERVIX WITH AND WITHOUT LABOR
0573 BREECH PRESENTING TWINS: IS VAGINAL DELIVERY SAFE?
0574 COMPARISON OF THE PERINATAL MORBIDITY AND MORTALITY OF THE PRESENTING TWIN TO ITS CO-TWIN
0575 THE OUTCOME OF VAGINALLY DELIVERED TWIN GESTATIONS WITH LARGER BIRTH WEIGHT IN TWIN B
0576 OPERATIVE DELIVERY IN TWINS
0577 MODE OF DELIVERY OF SINGLETON BREECH: 11-YEAR EXPERIENCE AT A SINGLE CENTER
0578 DIURNAL PATTERNS OF UTERINE CONTRACTIONS PRIOR TO PRETERM LABOR
0579 THE NEONATAL CONSEQUENCES OF SINGLETON DELIVERY AT 33 THROUGH 36 WEEKS’ GESTATION
0580 IS THERE AN ADVANTAGE TO EARLY DELIVERY IN MONOAMNIOTIC TWIN GESTATIONS?
0581 INTERPREGNANCY INTERVAL IN ADOLESCENTS—EFFECT OF POSTPARTUM CHOICE OF CONTRACEPTION
0582 PLACENTAL HISTOLOGY AND INVASIVENESS OF NEONATAL GROUP B STREPTOCOCCUS
0583 SUBLINGUAL NITROGLYCERIN AS TOCOLYTIC IN EXTERNAL CEPHALIC VERSION: A COMPARATIVE STUDY
0584 ANTENATAL MAGNESIUM EXPOSURE AND NEONATAL DEMISE
0585 PAINLESS VS SYMPTOMATIC PRIOR SECOND-TRIMESTER LOSS: WHICH IS MORE PREDICTIVE OF SUBSEQUENT PRETERM DELIVERY?
0586 PREVALENCE OF ABNORMAL KARYOTYPES IN FIRST- OR SECOND-TRIMESTER LOSSES
0587 NEONATAL OUTCOME OF DISCORDANT TWIN GESTATIONS
0588 TWELVE-YEAR EXPERIENCE OF QUADRUPLET PREGNANCIES AT A SINGLE INSTITUTION
0589 MATERNAL MORBIDITY AND OBSTETRICAL COMPLICATIONS OF QUADRUPLET PREGNANCY: TWELVE-YEAR EXPERIENCE AT A SINGLE INSTITUTION
0590 NEONATAL OUTCOMES OF QUADRUPLET PREGNANCIES: TWELVE-YEAR EXPERIENCE AT A SINGLE INSTITUTION
0591 PRETERM LABOR COMPLICATING QUADRUPLET PREGNANCY: TWELVE-YEAR EXPERIENCE AT A SINGLE INSTITUTION
0592 OBSTETRIC ANTECEDENTS TO INFANTS DELIVERED WITH AN APGAR SCORE OF 0 AT 1 MINUTE
0593 MANAGEMENT OF PREGNANCY AT 23 WEEKS’ GESTATION: CURRENT PRACTICE PATTERNS AMONG PERINATOLOGISTS
0594 CORRECTED MATERNAL WEIGHT GAIN DURING PREGNANCY IS NOT ASSOCIATED WITH FETAL MACROSOMIA
0595 FETAL HEAD POSITIONING DURING THE ACTIVE PHASE OF LABOR: CORRELATION BETWEEN TRANSVAGINAL DIGITAL EXAMINATION AND TRANSABDOMINAL ULTRASOUND ASSESSMENT
0596 VELAMENTOUS CORD INSERTION AS A PROGNOSTIC FACTOR IN TWIN GESTATIONS
0597 VELAMENTOUS CORD INSERTION AS AN ETIOLOGIC AND PROGNOSTIC FACTOR IN TWIN-TWIN TRANSFUSION SYNDROME
0598 RESPIRATORY MORBIDITY OF WELL-DATED TWINS AFTER 35 WEEKS: WHAT ARE THE RISKS OF ELECTIVE DELIVERY?
0599 ANTENATAL STEROIDS IN TRIPLET PREGNANCIES
0600 Withdrawn
0601 IMPACT OF METHOD OF CONCEPTION; SPONTANEOUS VS IN VITRO FERTILIZATION/INTRACYTOPLASMIC SPERM INJECTION ON PERINATAL AND NEONATAL OUTCOMES IN TRIPLET PREGNANCIES
0602 OUTCOMES OF DICHORIONIC TRIPLET PREGNANCIES
0603 TOXIC TRACE ELEMENTS (TE) CAN BE FOUND IN THE MATERNAL AND FETAL COMPARTMENTS
0604 THE INTRAVENOUS FORMATION OF THE DEVELOPING PLACENTAL BASAL PLATE TISSUE INVOLVES BOTH MATERNAL PROTEINS AND FETAL ONCOFETAL FIBRONECTIN
0605 REVIEW OF MONOAMNIOTIC GESTATIONS REPORTED IN THE ENGLISH LANGUAGE LITERATURE FROM 1988 TO 1999
0606 NORMAL PROGRESSION OF THE TDxFLM II ASSAY IN THE LATE THIRD TRIMESTER
0607 THE EFFECT OF MODE OF DELIVERY AND INCREASING LENGTH OF GESTATION ON NEONATAL MORBIDITY IN TWINS
0608 THE RISK OF FETAL DEATH IN MULTIPLE PREGNANCY: THE ROLE OF GESTATIONAL AGE
0609 NEONATAL MORBIDITIES IN TERM TWIN PREGNANCIES: THE EFFECT OF ZYGOSITY
0610 PRENATAL INTERVENTIONS TO IMPROVE OUTCOMES IN TWIN PREGNANCIES
0611 THE MENTAL AND MOTOR DEVELOPMENT OF TWIN CHILDREN: THE ROLE OF ZYGOSITY
0612 TWINS: CERCLAGE OR NO CERCLAGE?
0613 RISK FACTORS FOR PLACENTA ACCRETA IN NULLIPAROUS PATIENTS
0614 FACTORS INFLUENCING COMBINED VAGINAL-CESAREAN SECTION DELIVERY OF TWIN PREGNANCIES
0615 OUTCOME OF TWIN GESTATIONS: HISPANIC VS NON-HISPANIC WOMEN
0616 ESTIMATION OF GESTATIONAL AGE IN THE THIRD TRIMESTER WITH TRANSVERSE CEREBELLAR DIAMETER
0617 DISCORDANT TWIN GROWTH: THE EFFECTIVENESS OF PRENATAL ULTRASOUND SCANNING AS A SCREENING TOOL
0618 DIFFERING DOSE-RESPONSE OF PRENATAL ALCOHOL EXPOSURE FOR BEHAVIORAL OUTCOMES AT AGE 6 TO 7
0619 RISK OF SECOND-TRIMESTER SPONTANEOUS ABORTION IN TRIPLETS
0620 RISK FACTORS FOR SMALL–FOR–GESTATIONAL AGE BIRTHS BETWEEN BLACK AND WHITE ADOLESCENTS IN THE UNITED STATES
0621 ABNORMAL CORD INSERTIONS IN TWIN PREGNANCIES: ASSISTED REPRODUCTION VS SPONTANEOUS CONCEPTION
0622 PREOPERATIVE VAGINAL PREPARATION WITH POVIDONE-IODINE DECREASES THE RISK OF POST-CESAREAN ENDOMETRITIS
0623 SUICIDE ATTEMPTS DURING PREGNANCY BY POISONING: REPORT FROM A NATIONAL DATABASE—1999
0624 ETHNICITY-SPECIFIC NORMS FOR FETAL CROWN-RUMP LENGTH
0625 CESAREAN SECTION FOR CPD IN THE SECOND STAGE OF LABOR
0626 INCREASED RISK FOR CESAREAN DELIVERY AFTER A TRIAL OF LABOR WITH ADVANCING MATERNAL AGE: CESAREAN INDICATIONS AND ROLE OF INDUCTION
0627 TRIAL OF LABOR COMPARED WITH ELECTIVE REPEAT CESAREAN SECTION IN TWIN GESTATIONS WITH PREVIOUS CESAREAN DELIVERY
0628 SPONTANEOUS VERSUS INDUCED LABOR WITH A PREVIOUS CESAREAN SECTION
0629 OUTCOMES OF TRIAL OF LABOR AFTER PREVIOUS CESAREAN AMONG WOMEN WITH FETUSES >4000 GRAMS (MACROSOMIC FETUSES)
0630 CESAREAN SECTION ON MATERNAL REQUEST: A FOUR-YEAR EXPERIENCE
0631 ELECTIVE REPEAT CESAREAN SECTION AND FAILED VAGINAL BIRTH AFTER CESAREAN SECTION HAVE THE SAME INCREASED RISK FOR MAJOR OPERATIVE INJURIES
0632 TEACHING FORCEPS: THE IMPACT OF PROACTIVE FACULTY
0633 REDUCED MATERNAL MORBIDITY WITH ROTATIONAL KEILLAND FORCEPS DELIVERY FROM THE OCCIPUT POSTERIOR POSITION
0634 REGIONAL MANAGEMENT OF THE VLBW (≤1500 GRAM) IN BREECH PRESENTATION
0635 REGIONAL MANAGEMENT OF THE VLBW (≤1500 GRAM) IN CEPHALIC PRESENTATION
0636 DOES UTERINE WIPING INFLUENCE THE RATE OF POST CESAREAN ENDOMETRITIS?
0637 ANTEPARTUM, INTRAPARTUM, AND NEONATAL SIGNIFICANCE OF EXERCISE ON HEALTHY, LOW-RISK PREGNANT WOMEN
0638 WHAT ARE THE RISK FACTORS FOR A BIRTH INJURY DIAGNOSED AFTER A CESAREAN DELIVERY?
0639 MATERNAL AGE AS A PREDICTOR OF SYMPTOMATIC UTERINE RUPTURE DURING A TRIAL OF LABOR AFTER PRIOR CESAREAN DELIVERY
0640 POSTCESAREAN FEVER AND UTERINE RUPTURE IN A SUBSEQUENT TRIAL OF LABOR
0641 Withdrawn
0642 ELECTIVE REPEAT CESAREN SECTION: CAN IT COST LESS THAN A TRIAL OF LABOR?
0643 VAGINAL DELIVERY OF SECOND NONVERTEX TWIN—A SAFE OPTION
0644 ASSOCIATION BETWEEN MAGNESIUM AND INTRAVENTRICULAR HEMORRHAGE
0645 MAGNESIUM SULFATE IS NO MORE EFFICACIOUS THAN OTHER TOCOLYTIC AGENTS
0646 A PROSPECTIVE EVALUATION OF FETAL LACERATION INJURY AT DELIVERY
0647 DETERMINANTS OF PERINATAL MORBIDITY AND DEATH AMONG THE SECOND OF TWINS
0648 ADNEXAL MASSES IN PREGNANCY: MATERNAL AND FETAL IMPLICATIONS
0649 SERUM BILE ACIDS AS AN INDICATOR OF INTRAHEPATIC CHOLESTASIS OF PREGNANCY
0650 GENETIC THROMBOPHILIA AND THROMBOEMBOLIC COMPLICATIONS
0651 LONGITUDINAL STUDY OF THE EFFECT OF HEPARIN DURING PREGNANCY ON BONE MINERAL DENSITY AND BONE MARKERS
0652 PREGNANCY OUTCOME AFTER LOOP ELECTROSURGICAL EXCISION PROCEDURE OF THE CERVIX
0653 ASSOCIATIONS OF PULMONARY EDEMA IN PATIENTS DELIVERING PREMATURELY
0654 INFLUENCE OF PRIOR PREGNANCIES ON DISEASE COURSE AND MORTALITY IN SYSTEMIC SCLEROSIS
0655 THE MATERNAL-FETAL MEDICINE/CRITICAL CARE TEAM: ITS IMPACT ON OTHER SPECIALTY CONSULTATIONS DURING OBSTETRIC INTENSIVE CARE UNIT ADMISSIONS
0656 NEPHROLITHIASIS AND URETEROLITHIASIS IN PREGNANCY: TRIMESTER OF OCCURRENCE, MANAGEMENT, AND TECHNIQUE OF DIAGNOSIS
0657 MECHANICAL VENTILATION AND CESAREAN SECTION IN A CRITICALLY ILL OBSTETRIC POPULATION: AN EXTREMELY GRAVE PROGNOSTIC FACTOR
0658 THE COST-EFFECTIVENESS OF INTERMITTENT PNEUMATIC COMPRESSION FOR THROMBOPROPHYLAXIS AT THE TIME OF CESAREAN DELIVERY
0659 TREATMENT REGIMEN IS MORE PREDICTIVE OF ASTHMA SEVERITY DURING PREGNANCY THAN CURRENT NAEP CRITERIA
0660 THE PROGNOSTIC IMPLICATIONS OF HELICOBACTER PYLORI SEROPOSITIVITY IN PATIENTS WITH HYPEREMESIS GRAVIDARUM
0661 VENOUS THROMBOEMBOLISM AND ASSOCIATED THROMBOPHILIAS IN PREGNANCY
0662 ARTHROPOD ENVENOMATIONS DURING PREGNANCY: REPORT FROM A NATIONAL DATABASE—1999
0663 THE EFFECTS OF GESTATIONAL AGE AND POSITION ON PEAK EXPIRATORY FLOW RATE: A LONGITUDINAL STUDY
0664 THE EFFECT OF SUMATRIPTAN ON THE UTERINE CONTRACTILITY OF HUMAN MYOMETRIUM
0665 SINGLE VERSUS MULTIPLE DOSES OF GENTAMICIN IN THE TREATMENT OF PYELONEPHRITIS DURING PREGNANCY: A RANDOMIZED CONTROLLED TRIAL
0666 CHOLESTASIS OF PREGNANCY MANAGED EXPECTANTLY IS NOT ASSOCIATED WITH ADVERSE FETAL OUTCOME: A COMPARATIVE STUDY OF 89,135 PATIENTS
0667 DIFFERENCE IN BIRTH WEIGHT CANNOT BE USED TO PREDICT SUCCESS/FAILURE OF VBAC ATTEMPTS AMONG THOSE WITH A PRIOR CESAREAN SECTION FOR CEPHALOPELVIC DISPROPORTION
0668 COMPARISON OF EARLY AND DELAYED FEEDING POST–CESAREAN DELIVERY
0669 CESAREAN DELIVERY FOR EXTREMELY LOW–BIRTH–WEIGHT INFANTS 500 TO 750 GRAMS IN BREECH PRESENTATION: WHAT ARE THE BENEFITS?
0670 BREECH PRESENTATION IN PRIMIPAROUS WOMEN: IS VAGINAL DELIVERY SAFE?
0671 ASSESSMENT OF RISK WITH TRANSABDOMINAL CERCLAGE
0672 FACTORS ASSOCIATED WITH SEVERE PERINEAL LACERATIONS IN WOMEN UNDERGOING OPERATIVE VAGINAL DELIVERY
0673 MATERNAL ANTHROPOMETRIC EFFECTS ON THE SUCCESS RATES OF EXTERNAL CEPHALIC VERSION